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Zusammenfassung 
 
Es besteht ein grosses medizinisches Interesse an der Identifizierung von Genen, welche an 
der Entstehung komplexer, häufiger Krankheiten des Menschen beteiligt sind. Eine solche 
Krankheit ist die alters-korrelierte Makuladegeneration (AMD). Die AMD ist eine der 
häufigsten Ursachen für den Verlust der Sehfähigkeit im Alter von über 75 Jahren. Obwohl 
die Erblindung bei der AMD letztlich durch das Absterben von Photorezeptor-Zellen in der 
zentralen Retina bedingt wird, gibt es genügend Hinweise dafür, dass die  Pathogenese der 
AMD ihren Ausgang vom retinalen Pigmentepithel (RPE) nimmt (Liang and Godley, 2003).  
 
Ziel dieser Arbeit war die Identifizierung und Charakterisierung von RPE-spezifischen Genen 
als Beitrag zur umfassenden Charakterisierung des RPE-Transkriptoms. Darüberhinaus war es 
Ziel der Arbeit, die mögliche Rolle der RPE-spezifischen Gene bei der Entstehung der AMD 
zu explorieren. Ausgangspunkt der Arbeit war eine RPE-spezifische, bovine cDNA 
Bibliothek, welche in der Arbeitsgruppe auf der Grundlage der SSH-Technik (Diatchenko et 
al, 1996, 1999) hergestellt worden war. Die SSH-Technik gestattet die Anreicherung von 
differentiell exprimierten Genen bei gleichzeitiger Normalisierung redundanter Sequenzen. 
Mit Hilfe des Software-Programms CAP3 (Huang and Madan, 1999) wurden insgesamt 2379 
ESTs gruppiert und geordnet. 1,2% der 2379 RPE-ESTs enthielten Vektor Sequenzen und 
wurden daher von der weiteren Analyse ausgeschlossen. 5% der RPE-ESTs wiesen 
Homologien zu multiplen Chromosomen auf und wurden daher ebenfalls von der weiteren 
Analyse ausgeschlossen. Die übrigen 2245 ESTs wurden in 175 Contigs und 509 Singletons 
gruppiert, woraus sich Hinweise auf insgesamt  684 putative Einzelgene ergaben. 343 dieser 
684 Klone zeigten jedoch keine Homologien zu humanen orthologen Sequenzen. Ursache für 
die fehlende Homologie muss in der grossen Zahl der Klone gesehen werden, bei welchen nur 
die 3´untranslatierten verglichen wurden. Im Gegensatz zu den kodierenden 
Sequenzabschnitten kommt es in den nicht-kodierenden Regionen in der Regel zu einer 
relativ raschen evolutionären Divergenz und damit zum Verlust der Homologie (Sharma et al, 
2002). Durch zusätzliche Sequenzierung und Sequenzvergleiche der kodierenden Bereiche 
dieser 343 Klone lassen sich möglicherweise weitere RPE-spezifische Gene finden.  
 
Um die grosse Anzahl der im Rahmen des RPE-Projektes generierten Daten bearbeiten zu 
können wurde eine sehr effiziente und Benutzer-freundliche Datenbank auf Grundlage des 
RDBMS-Moduls etabliert. Dieses System gestattet die interaktive Bearbeitung der 
gespeicherten Daten im Query-Format. Darüberhinaus können die Daten in beliebiger Weise 
annotiert und verbunden werden.  
 
Nach Abzug der 343 nicht-homologen cDNA Klone von den 684 putativen Einzelsequenzen 
verblieben 341 Kandidaten-Sequenzen. 2 dieser Sequenzen wurden als putative neue RPE-
spezifische Gene einer weiteren Analyse zugeführt. Dabei wurde zunächst die RPE- bzw. 
Retina-Spezifität dieser Kandidaten-Sequenzen mit Hilfe der RT-PCR Analyse bestätigt. Als 
Basis für zukünftige Fall-Kontroll- und Assoziationsstudien wurde eine SNP-Genotypisierung 
eines dieser zwei Klone (ursprüngliche Bezeichnung: RPE01-D2; derzeitige Bezeichnung: 
RDH12) durchgeführt. Die direkte Sequenzanalyse umfasste 23.4 kb und ergab insgesamt 12 
SNPs, von denen sich 5 als hoch-informativ erwiesen. Auf dieser Grundlage können 
zukünftig Allel-Frequenzen zwischen Kontrollpersonen und AMD-Patienten ermittelt und 
verglichen werden. Zukünftig werden darüberhinaus real-time PCR Methoden zur 
Expressionsanalyse der verbliebenen Kandidaten-Klone eingesetzt.  
 
Zusammenfassend liefert die vorliegende Arbeit einen Beitrag zum Verständnis der 
genetischen Grundlagen der RPE-Funktionen und trägt zur Aufklärung der Rolle von RPE-
spezifischen Genen bei der Disposition zur AMD bei. Zusätzlich ergaben sich Hinweise auf 
Kandidatengene, welche möglicherweise in der Pathogenese der AMD eine Rolle spielen.  
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SUMMARY 
 
There is substantial interest in the identification of genes underlying susceptibility to 
complex human diseases because of the potential utility of such genes in disease 
prediction and therapy. The complex age-related macular degeneration (AMD) is a 
prevalent cause of legal blindness in industrialized countries and predominantly 
affects the elderly population over 75 years of age. Although vision loss in AMD 
results from photoreceptor cell death in the central retina, the initial pathogenesis 
likely involves processes in the retinal pigment epithelium (RPE) (Liang and Godley, 
2003).  
 
The goal of the current study was to identify and characterize genes specifically or 
abundantly expressed in the RPE in order to determine more comprehensively the 
transcriptome of the RPE. In addition, our aim was to assess the role of these genes in 
AMD pathogenesis. Towards this end, a bovine cDNA library enriched for RPE 
transcripts was constructed in-house using a PCR-based suppression subtractive 
hybridization (SSH) technique (Diatchenko et al., 1996, 1999), which normalizes for 
sequence abundance and achieves high enrichment for differentially expressed genes. 
CAP3 (Huang and Madan, 1999) was used to assemble the high quality sequences of 
all the 2379 ESTs into clusters or singletons. 1.2% of the 2379 RPE-ESTs contains 
vector sequences and was excluded from further analysis. 5% of the RPE-ESTs 
showed homology to multipe chromosomes and were not included in further assembly 
process. The rest of the ESTs (2245) were assembled into 175 contigs and 509 
singletons, which revealed approximately 684 unique genes in the dataset. Out of the 
684, 343 bovine RPE transcripts did not align to their human orthologues. A large 
fraction of clones were shown to include a considerable 3´untranslated regions of the 
gene that are not conserved between bovine and human. It is the coding regions that 
can be conserved between bovine and human and not the 3’ UTR (Sharma et al., 
2002). Therefore, more sequencing from the cDNA library with reclustering of those 
343 ESTs together with continuous blasting might reveal their human orthologoues. 
 
To handle the large volume of data that the RPE cDNA library project has generated a 
highly efficient and user-friendly RDBMS was designed. Using RDBMS data storage 
can be managed efficiently and flexibly. The RDBMS allows displaying the results in 
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query-based form and report format with additional annotations, links and search 
functions.  
 
Out of the 341 known and predicted genes identified in this study, 2 were further 
analyzed. The RPE or/and retina specificity of these two clones were further 
confirmed by RT-PCR analysis in adult human tissues. Construction of a single 
nucleotide polymphism (SNP) map was initiated as a first step in future case/control 
association studies. SNP genotyping was carried out for one of these two clones 
(RPE01-D2, now known as RDH12). 12 SNPs were identified from direct sequencing 
of the 23.4-kb region, of which 5 are of high frequency. In a next step, comparison of 
allele frequencies between AMD patients and healthy controls is required. 
Completion of the expression analysis for other predicted genes identified during this 
study is in progress using real time RT-PCR and will provide additional candidate 
genes for further analyses.  
 
This study is expected to contribute to our understanding of the genetic basis of RPE 
function and to clarify the role of the RPE-expressed genes in the predisposition to 
AMD. It may also help reveal the mechanisms and pathways that are involved in the 
development of AMD or other retinal dystrophies. 
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I INTRODUCTION 
1.1 Structure and function of the retinal pigment epithelium (RPE) 
 
The retinal pigment epithelium (RPE) consists of a monolayer of cuboidal cells that is 
situated between the fenestrated vasculature of the choriocapillaris and the 
photoreceptor cells of the neurosensory retina (Marmor, 1998). The RPE is polarized 
with the apical RPE cell surface facing the photoreceptors, and its basal infoldings 
functionally linked to the choroid via Bruch’s membrane, a five-layered structure of 
the extracellular matrix. The apical and basal membranes of the RPE cells are 
differentiated with regard to receptoral and ion channel properties. The sodium-
potassium pump is present on the apical membrane, whereas the chlorid-bicarbonate 
exchange transporter is on the basal membrane (Figure 1) (Marmor, 1998).  
The RPE gets its name from the melanin pigment that is present within cytoplasmic 
granules called melanosomes (Marmor, 1998). These granules begin to fuse with 
lysosomes and break down with aging process. This is the reason why the elderly 
fundus appears less pigmented. The melanin absorbs light that has been captured by 
the photoreceptors and prevents excessive light scattering within the eye. Although 
the molecular mechanism of photoprotection is not fully understood, melanin has 
been postulated to act as a cellular antioxidant (Sarna et al., 2003). New findings 
show that the melanin granules are connected to the lysosomal degradation pathway, 
and that a deficit of melanin pigment is associated with age-related macular 
degeneration (AMD).  
Another RPE pigment is lipofuscin that accumulates in RPE cells with age, it can 
occupy up to 19% of cytoplamic volume by the age of 80 (Feeney-Burns et al., 1984). 
Lipofuscin is thought to be accummulated as a result of the highly oxidative retinal 
environment, which may oxidize proteins and polyunsaturated fatty acids (PUFA) that 
are abundant in photoreceptor outer segments (POS) and autophagocytic debris, 
rendering them refractory to lysosomal action (Shamsi and Boulton, 2001). This leads 
to progressive lipid accumulation seen with aging and the formation of basal laminar 
and basal linear deposits and drusen that are present in lesions of AMD (Curcio and 
Millican, 1999). It has been reported that basal linear and soft drusen are diffuse and 
focal deposits, respectively, of the same membranous material (Sarks et al., 1980) and 
that membranous debris in Bruch membrane (BM) is associated with AMD. 
Although, the role of basal deposits in the development of late AMD, characterized by 
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choroidal neovascularization (CNV) and geographic atrophy of the RPE, remains 
controversial, the presence of basal linear deposits is thought to place an eye at risk 
for late AMD (Curcio and Millican, 1999). Up to 40 hydrolytic enzymes are present 
within lysosomes of which cathepsin D together with cathepsin S has been shown to 
be important in the breakdown of POS (Eldred, 1998). 
Figure 1 Diagram of a retinal pigment epithelial (RPE) cell. Note the microvilli projecting from the 
apical surface and the extensive infoldings on the basal surface of the RPE cell. Melanin granules are 
more numerous in the apical region, whereas lipofuscin particles are more abundant in the central and 
basal areas. Other organelles shown include those present in all cell types (nucleus, mitochondria, 
lysosomes, endoplasmic reticulum, and Golgi). In addition, the RPE contains specialized organelles 
such as melanin, phagosomes, and phagolysosomes (from Marmor, 1998). 
 
The essential physiologic functions of the RPE include the selective diffusion and 
transport of ions, metabolites, and serum components to the outer retina (Hughes et 
al., 1998); transport, storage, and processing of vitamin A and its derivatives; the 
absorption of scattered light by RPE melanin granules; and the synthesis of basement 
membrane components, including fibronectin, laminin, collagen, and 
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glycosaminoglycans, all of which are important to RPE adhesion to and maintenance 
of Bruch’s membrane. Table 1 summarizes some of the major known functional 
characteristics of the RPE (Marmor, 1998). 
 
Table 1 Physiological roles of the RPE* 
Pigment functions 
 Light adaptation and screening 
 Detoxification and binding 
 Lipofuscin accumulation 
 Antigenic properties 
 
Environment and metabolic control 
 Blood-retina barrier 
 Transport of nutrients and ions 
 Dehydration of subretinal space 
 Synthesis of enzymes, growth factors, pigments 
 Interaction with endocrine, vascular and proliferative factors 
 
Visual pigment cycle 
 Capture and storage of vitamin A 
 Isomerization of all-trans to 11-cis vitamin A 
 
Interphotoreceptor matrix and retinal adhesion 
 Specialized matrix ensheathment of rods and cones 
 Metabolic control of adhesion 
 
Outer segment phagocytosis and aging 
 Phagocytosis of outer segments tips 
 Digestion and recyling of membrane material 
 Aging effects: lipofuscin, drusen 
 Deposits and alterations in Bruch’s membrane 
 
Electrical activity 
 Responses to light-induced ionic changes 
 Responses to light-induced chemical signals 
 Nonphotic responses to chemical agents 
 
Repair and rectivity 
 Repair and regeneration 
 Immunologic interactions 
 Scarring and pigment migration 
 Modulation of fibrovascular proliferation 
 
* This table was adopted from (Marmor, 1998). 
                                                                                       Introduction             6
On its apical side the RPE contributes to the formation and maintenance of the 
interphotoreceptor matrix (IPM) that is critical for retinal adhesion. Recent studies 
have shown that the IPM is a highly structured with chemically independent domains 
surrounding the rods and cones (Marmor, 1998).  The matrix serves as a pathway for 
retinoids, nutrients and other substances to cross the subretinal space, and it appears to 
be an important domain for the elaboration of binding and receptoral proteins that 
assist control the photoreceptor environment.  
 
1.2 The RPE and hereditary diseases 
The RPE is involved in a wide variety of congenital, inherited, and metabolic 
disorders, although few have been identified in terms of specific cellular dysfunction 
at the level of the RPE. This might be due to the intimate interplay between retina and 
RPE pathophysiology, and overlap between the expression in the retina or RPE of 
genetic abnormalities. However, as the physiological functions of the RPE become 
well understood, we are realizing that the RPE is involved in the pathophysiology of 
many disorders that were once identified as affecting purely the choroid or the retina. 
Congenital abnormalities of the RPE include albinism and congenital hypertrophy of 
the RPE. Albinism is a subgroup of disorders arising from a reduction of melanin 
pigment in the RPE. Pigment deficits in the RPE also lead to a reduction in the 
number and distribution of photoreceptors and other retinal cells by affecting the 
mechanisms controlling cell proliferation during the early development of the retina. 
Another common condition involving RPE is retinitis pigmentosa, a group of 
disorders characterized by slow degeneration of the photoreceptors with hereditary 
transmission. RPE degeneration is present in many other retinal dystrophies such as 
Stargardt's disease, pattern dystrophies, choroideremia, and photic maculopathy. 
Retinal detachment resulting from loss of the adhesive function of the RPE can also 
cause photoreceptor degeneration. 
 
A number of studies have attempted to transplant RPE to the subretinal space in 
various animal models (Lavail et al., 1992; He et al., 1993; Sheng et al., 1995). RPE 
transplants have also been attempted in humans with macular degeneration using 
cultured and freshly isolated homologous fetal RPE, the results have been 
disappointing in most parts due to immunological rejection (Algvere et al., 1999). 
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Transplantation of autologous RPE cells is not feasible because it is difficult to obtain 
autologous RPE cells, and the cells could possibly carry a genetic defect because they 
would be obtained from a patient bearing the disease to be treated. Recently, it has 
been suggested that autologous iris pigment epithelium (IPE) cells which can be 
easily obtained, may be an appropriate substitute for RPE cells for transplantation into 
the subretinal space to treat diseases in which the RPE loses its function (Thumann, 
2001). In vitro studies have shown that IPE cells have the potential to carry out many 
functions characteristic of RPE cells, e.g., retinol metabolism (Thumann et al., 1999). 
Understanding the factors which control RPE growth and proliferation is central to 
effective RPE or IPE transplantation.   
 
1.3 The RPE and age-related macular degeneration (AMD)  
AMD is a prevalent cause of legal blindness in industrialized countries and 
predominantly affects the elderly population over 75 years of age. AMD is a 
degenerative condition of the cone-rich central retinal called the macula, and its 
prevalence is rising with increasingly aging populations (Leibowitz et al., 1980; Klein 
et al., 1992). Despite the high incidence and severity of vision impairment, only a 
limited percentage of AMD patients are amenable to treatment (Ciulla et al., 1998). 
 
The clinical and histopathological features of AMD include a strong relationship with 
age, and the presence of pigmentary disturbances, drusen, thickening of Bruch's 
membrane, and basal laminar deposits with normal visual acuity to large areas of RPE 
atrophy or choroidal neovascularization. Drusen are subretinal pigment epithelial 
deposits (Figure 2) that are characteristic of but not uniquely associated with AMD 
(Hageman et al., 2001). Small, hard drusen with well-defined edges are present in 
more than 90% of eyes in old people and are usually not considered to be 
pathological. On the other hand, larger soft drusen are diagnosed as early AMD (Bird 
et al., 1995; Curcio and Millican, 1999). Late AMD is divided into two clinical 
subtypes: (i) atrophic or ‘dry’ AMD, characterized by accumulation of drusen within 
and under the RPE and atrophy of the macular retina and RPE; and (ii) exudative or 
‘wet’ AMD, typified by invasion of abnormal blood vessels into the subretinal space 
from the choroid and subsequent disciform degeneration. Although the vision loss of 
AMD results from photoreceptor damage in the central retina, the initial pathogenesis 
involves degeneration of the RPE (Green et al., 1985; Spraul et al., 1996; Zarbin, 
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1998). While the causes of AMD are not conclusively known, it thought that multiple 
factors may be involved including environmental, nutritional and genetic components. 
Thus, AMD is considered a multifactorial disease caused by genetic as well as 
environmental factors. 
 
1.3.1 Evidence for genetic and environmental factors in AMD susceptibility 
Several studies suggest that there is a genetic component to AMD pathology. Twin 
studies have shown a higher concordance of AMD phenotypes among monozygotic 
(100%) than dizygotic (40%) twins (Meyers et al., 1995). Both clinic-based and 
population-based family studies have reported an increased risk of AMD among first-
degree relatives of affected individuals (Klaver et al., 1998; Seddon et al., 1997). The 
prevalence of AMD among first-degree relatives of subjects with AMD, particularly 
with exudative disease, is greater than among first-degree relatives of subjects without 
the disease. The data suggest that macular degeneration has a familial component and 
that genetic or shared environmental factors, or both, contribute to its development 
(Seddon et al., 1997). Family linkage studies have identified one possible locus for 
AMD on chromosome 1q (Klein et al., 1998). 
 
 
 
 
Figure 2. Light micrograph illustrating the appearance and location of "hard" drusen. Drusen 
are located in the sub-RPE space between the RPE basal lamina and the inner collagenous 
layer of Bruch's membrane (Asterisks); OS, photoreceptor outer segments; CH, choroid; IS, 
inner segments; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer  
(from Hageman et al., 2001).  
 
                                                                                       Introduction             9
The association of AMD with genetic factors is further supported by identification of 
the disease-associated gene for Stargardt disease (ABCR or ABCR4), a rare early 
onset macular dystrophy, which shows some overlapping clinical and pathological 
features with AMD (Allikmets et al., 1997; Briggs et al., 2001). The significance of 
ABCR gene sequence changes in AMD has been challenged by a number of studies 
that either identified methodologic deficiencies in the design of the study (Dryja et al., 
1998; Klaver et al., 1998) or failed to reproduce a significant association between 
ABCA4 and AMD (Rivera et al., 2000; Webster et al., 2001). The contribution of 
ABCA4 and its extent to AMD pathogenesis still remains to be demonstrated. Several 
other genes have been associated with inherited retinal dystrophies that also share 
some clinical manifestations and features with AMD. These include the gene 
encoding the tissue inhibitor of metalloproteinase-3 (TIMP3) resulting in Sorsby 
fundus dystrophy (Weber et al., 1994), the Best disease gene (VMD2) which is 
associated with Best macular dystrophy (Marquardt et al., 1998; Pertukhin et al., 
1998), the RDS/peripherin gene responsible for a proportion of adult vitelliform 
macular dystrophy/butterfly dystrophy (Felbor et al., 1997; Kohl et al., 1998) and the 
EGF-containing fibrillin-like extracellular matrix protein-1 (EFEMP1) associated 
with Malattia Leventinese/Doyne honeycomb retinal dystrophy (Stone et al., 1999). 
However, TIMP3 (De La Paz et al., 1997), VMD2 ( Krämer et al., 2000), EFEMP1 
(Stone et al., 1999), and RDS/peripherin (Shastry and Trese, 1999) have been 
comprehensively analyzed and excluded as a major factors in the predisposition to 
AMD. 
 
A genetic basis for AMD does not exclude an environmental influence on the disease 
process. Among the environmental factors, exposure to sunlight may be associated 
with the development of early AMD (Cruickshanks et al., 2001). In addition, several 
studies have reported a positive association between cigarette smoking and AMD 
(Hammond et al., 1996; ). Several studies have found a positive association between 
risk factors for cardiovascular disease and AMD (Hyman et al., 2000; AREDS Group, 
2000) while others have not (Klein et al., 2003). The Eye Disease Case Control Study 
(EDCCS Group, 1993) has demonstrated that higher serum carotenoid (beta carotene) 
levels seem to protect people from AMD. Among the specific carotenoids, lutein and 
zeaxanthin, which are primarily obtained from dark green, leafy vegetables, were 
most strongly associated with a reduced risk for AMD. The Macular Degeneration 
                                                                                       Introduction             10
Risk Factor Study has found less of the most serious type of AMD in patients with 
high antioxidant blood levels.  
 
1.3.2 Oxidative stress and AMD pathogenesis 
Evidence from a variety of studies suggests that RPE cells are susceptible to oxidative 
damage. From an anatomical point of view, RPE is located between the sensory retina 
and choroid, this location subsequently exposes RPE cells to a highly oxidative 
environment due to high oxygen partial pressure from the underlying choriocapillaris. 
Physiologically, RPE cells phagocytose and digest POS. Since the shed POS are 
extremely rich in PUFA, the oxidation of these PUFA initiates a chain reaction 
resulting in an abundance of reactive oxygen species (ROS), including lipid aldehyde 
radicals (Srivastava et al., 1995). During aging and pathological conditions, the 
balance between the ROS generation and the ROS clearance can be disturbed and 
result in oxidative damage to macromolecules (Ames et al., 1993; Harman, 1998). 
One of the most prevalent theories of aging is the mitochondrial theory. It proposes 
that oxidative damage to the mitochondria can lead to a spiral of confounding effects, 
whereby damaged mitochondria in turn release additional ROS, further increasing 
oxidative damage, and eventually leading to dysfunctional or defective mitochondria 
(Harman, 1981). Subsequently, cytochrome c is released into the cytoplasm, which 
initiates apoptosis through the activation of caspases that represents an early 
pathological event of AMD (Liang and Godley, 2003). The susceptibility of 
mitochondrial DNA to oxidative damage in the human RPE, together with the age-
related decrease of cellular anti-oxidants, provides the rationale for a mitochondria-
based model of AMD (for reivew, see  Liang and Godley, 2003).  
 
1.3.3 Growth factors and AMD 
By virtue of its location, RPE forms the outer blood-retina barrier, which facilitates 
the transport of selective molecules between the outer neural retina and the choroidal 
blood supply. Among various growth factors secreted from RPE cells, it was 
demonstrated that differentiated RPE cells express high levels of vascular endothelial 
growth factor (VEGF) and pigment epithelium-derived factor (PEDF). A critical 
balance between VEGF and PEDF is important to prevent the development of 
choroidal neovascularization (CNV) in AMD (Ohno-Matsui et al., 2001) which is 
characterized by the growth of new blood vessels from the choroid through Bruch’s 
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membrane into the subretinal pigment epithelial and subretinal space. These vessels 
can leak and bleed, leading to exudative retinal detachment and hemorrhage. 
Disturbed interactions of RPE cells with their surrounding extracellular matrix (ECM) 
could play a role in this process. The abnormal ECM may block normal signalling 
which could affect RPE adhesion and survival leading to degeneration and stimulating 
of angiogenic factors. A recent study reported that VEGF upregulates the production 
of PEDF by human RPE cells through VEGFR-1 in an autocrine manner (Ohno-
Matsui et al., 2003). This regulation leads to the restoration of a normal balance 
between angiogenic stimulators and inhibitors, and this balance might paly a key role 
in maintaining the homeostasis of the human retina. Several therapeutic approaches 
have been taken to inhibit VEGF signalling (Presta et al., 1997; Krzystolik et al., 
2002). 
 
1.3.4 Role of apoptosis in AMD 
Apoptosis is a genetically controlled mechanism of cell death characterized by a 
highly specific sequence of events that include cytoplasmic and nuclear condensation 
and fragmentation of nuclear chromatin (Wyllie et al., 1980). The mechanism of 
photoreceptor death is poorly understood, but one study found evidence of apoptosis 
of photoreceptors in 4 of 16 eyes with AMD using terminal deoxynucleotidyl 
transferase dUTP nick end-labeling (TUNEL) (Xu et al., 1996). A recent study 
reported that the number of TUNEL-positive cells in the choroid, RPE, outer nuclear 
layer (ONL), and inner nuclear layer (INL) is significantly greater in AMD eyes vs 
control eyes, suggesting that these cells may die by apoptosis (Dunaief et al., 2002). 
Moreover, the TUNEL-positive photoreceptors are clustered near areas of RPE 
atrophy and are mainly rods.  
 
1.3.5 Vitamin A metabolism and AMD 
Vitamin A and its derivatives play a central role in the vertebrate and invertebrate 
visual cycle (Saari, 2000). Retinoids function as the chromophores of the various 
visual pigments in animals, and photoisomerization of 11-cis-retinal to all-trans-
retinal is the initiating event in vision. The role of the RPE in the visual cycle became 
more clear with the demonstration that the critical enzymatic regeneration of the 11-
cis configuration occurred within this tissue (Bridges, 1976; Rando, 1996). Retinol 
uptake occurs at both the basolateral and apical surfaces of RPE by what appear to be 
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separate receptor-mediated processes. The release of a crucial retinoid, 11-cis 
retinaldehyde (11-cis retinal), occurs across the apical membrane. Delivery of retinol 
across the basolateral membrane is mediated by a retinol binding protein (RBP) that is 
secreted by the liver as a complex with retinol (vitamin A) (Bok, 1993).  
 
There is growing evidence for a key role for vitamin A in the formation of lipofuscin 
within the RPE. Rats maintained on a vitamin A deficient diet developed minimal 
autofluorecent material while rats raised on a high vitamin A diet accumulated 
significant amounts of lipofuscin-like fluorescence within the RPE. This has led to the 
conclusion that the accumulation of lipofuscin in rats is dependent on the dietary level 
of vitamin A (Katz et al., 1986). 
2. Genetic approaches to correlate the genotype with phenotype 
Two genetic approaches for revealing the genetic basis of human phenotypes are 
available, one that starts with a phenotype and concludes with the identification of a 
responsible gene or genes (positional cloning approach); the other  that begins with a 
gene and works toward identifying one or more phenotypes resulting from allelic 
variation of it, this is called candidate gene approach (Dryja, 1997). 
 
The first, the positional cloning approach (Collins, 1995), involves linkage analysis to 
identify the genetic region within which lies a disease-causing gene. Once the interval 
is of a manageable size, genes within the minimal region are tested as candidates for 
the disorder of interest. Over the last 15 years the technique of positional cloning has 
successfully been used to find disease genes. This technology has proven fruitful in 
the identification of genes for single gene disorders such as cystic fibrosis (Rommens 
et al., 1989), VMD2 (Marquardt et al., 1998;Petrukhin et al., 1998) and RS1 (Sauer et 
al., 1997). In positional cloning, the disease locus is mapped to a region of the 
genome using linkage studies in families affected with the disease. These regions are 
reduced in size using exclusion mapping techniques to give a small region of the 
genome (0.05 – 0.2%), in which to search for the gene. These single gene disorders 
are usually prevalent at low levels in the population, and are typically caused by a 
mutation in a single gene which results in an abnormal phenotype that is highly 
penetrant in family members who inherit the mutation. The allele frequency of these 
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mutations in the population is less than 1%. Variants present in the population in 
greater than 1% are designated as polymorphisms, rather than mutations. 
 
The second method, the candidate gene approach (Collins, 1995), involves examining 
individual genes that encode proteins with known functions or that have an expression 
profile that makes them candidates for the disorder in question. One factor that should 
be considered during the process of assessing any candidate gene is whether the gene 
is expressed in the tissue affected by the disorder. Alternatively, specifically or 
differentially expressed genes in a given tissue can be identified. Genes expressed in a 
certain tissue can be assumed to be important for the function of that tissue.  
 
Both methods are typically used simultaneously to discover genes causing hereditary 
disorders. Reductions in the cost and improvements in the speed of scanning 
individuals for DNA sequence variations may make a gene-based approach an 
efficient alternative to phenotype-based approaches to correlating genes with 
phenotypes (Dryja, 1997). Both approaches require a group of affected subjects who 
have been reliably diagnosed with the disease. Candidate gene approaches also 
require a reliable control group without the disease so that a clear distinction between 
polymorphisms and true mutations related to disease can be made.  
 
Many of the common diseases which affect millions of people, such as asthma and 
Alzheimer’s disease (AD), have an increased prevalence in certain families or 
populations. In these cases, the interaction of multiple disease susceptibility genes 
with environmental factors may lead to disease development. Asthma is a common 
respiratory disorder characterized by recurrent episodes of coughing, wheezing and 
breathlessness. Although environmental factors such as allergen exposure are risk 
factors in the development of asthma, both twin and family studies point to a strong 
genetic component. ADAM33 (a disintegrin and metalloproteinase domain 33) 
(Yoshinaka et al., 2002) represents one of the first putative asthma susceptibility gene 
identified through positional cloning in an outbred population (Van Eerdewegh et al., 
2002). Confirmation for linkage has come from the separate analysis of the UK and 
US families, and from two separate, previously published, genome wide studies in 
other UK and US outbred populations (Van Eerdewegh et al., 2002). Physical 
mapping and direct cDNA selection identified 40 genes in the region under the peak 
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of linkage. A survey of 135 polymorphisms in 23 genes identified the ADAM33 gene 
as being significantly associated with asthma using case-control, transmission 
disequilibrium and haplotype analyses. 
 
Various appraoches have been developed to isolate and identify differentially 
expressed genes in tissues or cells. These include differential display (Liang and 
Pardee, 1992), RNA fingerprinting using arbitrarily primed PCR (McClelland et al., 
1995), differential selection (Höög, 1991), and computer-based (in Silico) searches of 
public databases (Altschul et al., 1997), subtraction of cDNA libraries (Duguid and 
Dinauer, 1990), large scale generation of expressed sequence tags (ESTs) from cDNA 
libraries (Liew et al., 1994), serial analysis of gene expression (SAGE) (Velculescu et 
al., 1995), and suppression subtractive hybridization - SSH (Diatchenko et al., 1996 
and 1999). However, none of these techniques are free of  biases and are associated 
with a number of shortfalls. For example, SAGE although it is a very effective 
approach for determining the expression of mRNA populations, there are significant 
biases in the observed results that caused by sampling and sequencing error, 
nonrandomness and nonuniqueness of tag sequences (Stollberg et al., 2000). 
Suppression subtractive hybridization (SSH) is a technique that combines 
normaliation and subtraction. The abundant transcripts are suppressed, while rare 
transcripts are enriched to the same level of magnitude by normaliation. One of the 
objectives of using SSH technique is to isolate and identify genes that are enriched in 
the target tissue but not in the tissue or cell used as driver. This objective has the 
assumption that clones isolated by SSH are unique and only found in the target tissue, 
and therefore indicating their biological important. In addition, this might reveal a key 
physiological function specific of the tissue. 
Over the last decade, different computational methods have been developed to 
identify genes and determine their functions. The following section reviews the 
existing approaches to predicting genes in eukaryotic genomes and underlines their 
advantages and limitations. 
 
3. Computational methods for identifying genes 
The identification of coding sequences (CDS) is an important step in the functional 
annotation of gene sequences. CDS prediction for mammalian genes from genomic 
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sequence is complicated by the vast abundance of intergenic sequence in the genome, 
and provides little information about how different parts of potential CDS regions are 
expressed. Essentially, two different types of information are currently used to 
identify genes in a genomic sequences: (i) content sensors are measures that classify a 
DNA region into defined types, e.g. coding versus non-coding. (ii) signal sensors are 
measures that try to detect the presence of functional sites specific to a gene. 
 
A sequence similarity-based approach is founded on sequence conservation due to the 
functional constraints and is used to search for regions of similarity between an 
uncharacterized sequence of interest and already characterized sequences in a public 
sequence database. A query sequence can be compared with DNA, protein, or EST 
sequences or it can be searched for known motifs. If a query sequence is found to be 
significantly similar to an already annotated sequence (DNA or protein) the 
information from the annotated sequence can be used to possibly infer gene structure 
or function of the query sequence. The basic tools for detecting sufficient similarity 
between sequences are local alignment methods ranging from the optimal Smith–
Waterman algorithm to fast heuristic approaches such as FASTA (Pearson and 
Lipman, 1988) and BLAST (Altschul et al., 1990). Comparison with an EST database 
can provide information if the sequence of interest is transcribed, that is, contains an 
expressed gene, but will only give incomplete clues about the structure of the whole 
gene or its function, as ESTs only reflect a partial mRNA. Moreover, the correct 
attribution of EST sequences to an individual member in a gene family is not a trivial 
task. 
 
The second computational approach, for the prediction of gene structures in genomic 
DNA sequences, termed the template approach, integrates coding statistics with signal 
detection into one framework. Coding statistics behave in a different manner on 
coding and non-coding regions and they are measures indicative of protein coding 
potential. This coding statistic is usually implemented as a 5th order Hidden Markov-
Model (HMM). Signal sensors attempt to mimic closely processes occuring within the 
cell. They are intended to identify sequence signals, usually only several nucleotide-
long subsequences, which are recognized by the cell machinery and are the initiation 
of certain processes. The signals that are usually modeled by gene-finding programs 
are promoter elements, start and stop codons, splice sites, and polyadenylation sites. 
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Singal sensors are not sufficient to elucidate gene structure, and it is necessary to 
combine them with coding statistics methods in order to obtain satisfactory predictive 
power. 
 
A large body of literature on the subject of gene prediction has accumulated in the 
past 20 years. Early studies by a number of groups (Shepherd, 1981; Fickett, 1982; 
Staden and McLachlan, 1982) showed that statistical measures related to biases in 
amino acid and codon usage could be used to approximately identify protein coding 
regions in genomic sequences. Since then, numerous other compositional differences 
between coding and non-coding DNA sequences have been noted. Based on these 
differences, the first generation of gene prediction programs, designed to identify 
approximate locations of coding regions in genomic DNA were developed. The most 
known such programs are TestCode (Fickett, 1982), and GRAIL (Uberbacher and 
Mural, 1991), which uses a neural network approach to integrate multiple types of 
content statistics in order to classify sequence windows as coding or non-coding. 
These methods are generally able to identify coding regions of sufficient length, i.e. at 
least one or two hundred nucleotides, with fairly high reliability, but do not accurately 
predict precise exon locations. Second generation methods, such as SORFIND 
(Hutchinson and Hayden, 1992), GRAIL II (Xu et al., 1994) , use a combination of 
splice signal and coding region identification techniques to predict “spliceable open 
reading frames” i.e. potential exons), but do not attempt to assemble predicted exons 
into complete genes. Third generation methods attempt the more difficult task of 
predicting complete gene structures, i.e. set of exons which can be assembled into 
translatable mRNA sequences. Fourth generation methods of gene identification as 
exemplified by programs like GENSCAN (Burge and Karlin, 1997), has several 
significant advantages over existing gene finding algorithms. Predictive accuracy has 
been shown to be substantially higher for GENSCAN than for any other available method 
when tested on standardized sets of human and vertebrate genomic sequences. The 
program is able to identify 70 to 80% of exons in a genomic sequence precisely, with 
even higher levels of accuracy observed for complex genes containing ten or more 
exons (Burge and Karlin, 1997). Furthermore, a consistently high level of accuracy 
has been attained for sequencing of differing C+G% content. Other important features 
are the ability to treat partial as well as complete genes and the ability to predict 
multiple genes, occurring on either or both DNA strands, in a single sequence. These 
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features make GENSCAN useful for analysis of the long genomic contigs which are 
being generated at an increasing rate by the Human Genome Project and related 
genome sequencing efforts. Another noteworthy feature of the program is its ability to 
assign a meaningful reliability measure, the exon probability to each predicted exon, 
which gives the user a highly informative guide as to the degree of confidence which 
should ascribed to each aspect of a prediction.  
 
TWINSCAN is a new gene-structure prediction system that directly extends the 
probability model of GENSCAN, allowing it to exploit homology between two related 
genomes (Korf et al., 2001). Separate probability models are used for conservation in 
exons, introns, splice sites, and UTRs, reflecting the differences among their patterns 
of evolutionary conservation. TWINSCAN is specifically designed for the analysis of 
high-throughput genomic (HTG) sequences containing an unknown number of genes. 
In experiments on high-throughput mouse sequences, using homologous sequences 
from the human genome, TWINSCAN shows notable improvement over GENSCAN in exon 
sensitivity and specificity and dramatic improvement in exact gene sensitivity and 
specificity (Korf et al., 2001). This improvement can be attributed entirely to 
modeling the patterns of evolutionary conservation in genomic sequence (Korf et al., 
2001). 
 
The latest generation of gene prediction algorithms, such as Grail/Exp, Geni EST, 
GenomeScan, and SGP2 combine ab inito prediction with similarity data into a single 
probability model. The basic idea of the GenomeScan program is to combine sequence 
similarity information, which can indicate the approximate location of many coding 
exons, with modeling of exon–intron and splice signal composition to aid in 
identification of additional exons and for determination of precise exon–intron 
boundaries (Yeh et al., 2001). SGP2 is a new gene prediction program that combines ab 
initio gene prediction with TBLASTX searches between two genome sequences to 
provide both sensitive and specific gene predictions (Parra  et al., 2003). The accuracy 
of SGP2 when used to predict genes by comparing the human and mouse genomes is 
assessed on a number of data sets, including single-gene data sets, the highly curated 
human chromosome 22 predictions, and entire genome predictions from ENSEMBL 
(Parra  et al., 2003). It was found that SGP2 outperforms other ab initio gene prediction 
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methods. SGP2 was used to generate a complete set of gene predictions in both the 
human and mouse genomes. It was also reported that another few thousand human 
and mouse genes currently not in ENSEMBL (http://www.ensembl.org/) are worth 
verifying experimentally (Parra  et al., 2003). 
 
3.1 Public databases and sequence analysis tools 
In recent years, development of the technology for efficient, automated DNA 
sequencing has led to the accumulation of large databases of DNA and protein 
sequences, and a new field of study known as “computational molecular biology” or 
“bioinformatics” has started to take shape as researchers work to interpret and draw 
conclusions from this wealth of new information. Though difficult to define, the field 
might be described as the area of research at the intersection of molecular biology, 
molecular evolution and structural biology which seeks to understand the 
relationships between sequence, structure, evolution and biological function by 
statistical/computational analysis of molecular sequences. In the past decade, with the 
shift in the emphasis of the Human Genome Project (HGP) from physical mapping to 
intensive sequencing, the problem of the identification of the precise exon-intron 
sturctures of genes in higher eukaryotic and especially human genomic DNA 
sequences has taken on significant practical importance. 
 
The National Center for Biotechnology Information (NCBI) at the National Institutes 
of Health (USA) was created in 1988 to develop information systems for molecular 
biology. The main objective of NCBI was to maintain the GenBank (Benson et al., 
2000) nucleic acid sequence database, to which data are submitted directly by the 
scientific community. In addititon, to provide data retrieval systems and 
computational resources for the analysis of Genbank data and various other biological 
data made available through NCBI web site.  NCBI data retrieval tools include 
Entrez, LocusLink, PubMed and the Taxonomay Browser. Data analysis resources 
inlcude BLAST, Electronic PCR (e-PCR), OrfFinder, RefSeq, UniGene, 
HomoloGene, Database of Single Nucleotide Polymorphisms (dbSNP), Human 
Genome Sequencing, Gene Expression Omnibus (GEO), Online Mendelian 
Inheritance in Man (OMIM), Clusters of Orthologous Groups (COGs) database. The 
synchronization with the European Molecular Biology Laboratory (EMBL) Data 
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Library (Stoesser et al., 2003) and the DNA Data Bank of Japan (Tateno et al., 2002) 
provides comprehensive worldwide coverage. 
3.1.1 Sequences analysis resources 
3.1.1.1 BLAST 
BLAST (Basic Local Alignment Search Tool) is a family of sequence alignment 
algorithms (Altschul et al., 1990), and contains a collection of programs with versions 
for query-to-database pairs such as nucleotide- nucleotide (BLASTN), protein- 
nucleotide (BLASTX), protein-protein (BLASTP), nucleotide-protein (BLAST). 
BLAST uses a heuristic algorithm that seeks local as opposed to global alignments 
and is therefore able to detect relationships among sequences that share only isolated 
regions of similarity (Altschul et al., 1990). Successful searches return a set of gapped 
alignments between the query and similar database sequences, with links to the full 
database records. Each alignment receives a score and a measure of statistical 
significane, called expectation value, for judging the alignment quality. BLAST is 
used to identify whether a given sequence is novel, homologous to a known sequence, 
or contains protein motifs which may provide clues regarding a role for the sequence 
being queried (http://www.ncbi.nlm.nih.gov/BLAST/).  
  
An important and essential BLAST tool, BLAST2Sequences, compares two DNA or 
protein sequences and produces a dot-plot representation of the alignments in the form 
of a report (Tatusova and Madden, 1999). The NCBI generated assembly of both 
finished and unfinised human genome sequences can be searched through a 
specialized interface called Human Genome BLAST (http://www.ncbi.nlm.nih.gov/ 
genome/seq/page.cgi?F=HsBlast.html&&ORG=Hs). Human Genome BLAST shows 
custom ‘Genome View’ of the BLAST hits which is integrated with the Human 
Genome MapViewer, showing confirmed and predicted gene location, or EST hits. 
 
3.1.1.2 dbEST 
dbEST is the EST division of NCBI and contains sequence and mapping data on 
"single-pass" short (about 300-600 bp) cDNA sequences or expressed sequence tags  
from a number of organisms. Usually produced large numbers, the ESTs represent a 
snapshot of the genes expressed in a given tissue, and/or at a given developmental 
stage. dbEST release 062703 (as of July 6, 2003) contains 17291123 entries. Human 
and mouse are the most widely represented organisms in dbEST, with 5 372 189 and 
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3 780 061 entries, respectively (as of July 6, 2003) (http://www.ncbi.nlm.nih.gov/ 
dbEST/). 
 
3.1.1.3 Online Mendelian Inheritance in Man (OMIM) 
NCBI provides the online version of the OMIM catalog of human genes and genetic 
disorders (McKusick, 1998). The database contains information on disease 
phenotypes and genes, including extensive descriptions, gene names, inheritance 
patterns, map locations and gene polymorphisms (http://www.ncbi.nlm.nih.gov:80/                              
entrez/query.fcgi?db=OMIM). OMIM is updated daily, it contains 14598 entries, 
including data on 10839 established gene loci and 1358 phenotypic descriptions (as of 
July 3, 2003). 
 
3.1.1.4 dbSNP 
In collaboration with the National Human Genome Research Institute (NHGRI), The 
NCBI has established the dbSNP database to serve as a central repository for both 
single base nucleotide subsitutions and short deletion and insertion polymorphisms 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Snp). There is no requirement or 
assumption about minimum allele frequencies or functional neutrality for the 
polymorphisms in the database. Thus, the scope of dbSNP includes disease-causing 
clinical mutations as well as neutral polymorphisms. 
3.1.1.5 Pfam  
Pfam is a Protein families database of alignments and hidden Markov models 
(HMMs) covering many common protein domains and families. Pfam contains 
annotation of each family in the form of textual descriptions, links to other resources 
and literature references (http://pfam.wustl.edu/). Pfam version 10.0 (July 2003) 
contains alignments and models for 6190 protein families, based on the Swissprot 
41.10 and SP-TrEMBL 23.15 protein sequence databases. Pfam stores an HMM 
profile constructed from a seed sequence alignment (Eddy, 1998)  Pfam searches for 
matches to the HMMs. The Pfam database is invaluable for predicting the function of 
new sequences based on homology to previously characterised proteins. 
3.1.2 Database Retrieval Tools 
3.1.2.1 LocusLink 
The LocusLink database of official gene names and other gene identifiers  provides a 
single query interface to curated sequences and descriptive information about genes 
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(Pruitt and Maglott, 2001). LocusLink maintains descriptive information about loci 
including nomenclature, database identifiers, disease associations, map positions, 
sequence accessions, OMIM numbers, UniGene clusters, homology, map locations, 
and related web sites (http://www.ncbi.nlm.nih.gov/LocusLink/). The NCBI reference 
sequences (RefSeq) provide standards for complete genomic nucleic acids, assembled 
contigs, transcripts and protiens. 
 
3.1.2.2 Source 
Source is a web-based database that captures information from a broad range of 
resources, and provides it in manner particularly useful for genome-scale analyses 
(Diehn et al., 2003). Users can search for individual genes as well as simultaneously 
extract data for thousands of genes in batch. Source database can be searched using a 
gene symbol, the GenBank accession, the LocusLink identifier, or the UniGene 
cluster identifier. Source database also provides in silico generated expression 
calculated from EST abundance data. Other valuable features of the Source database 
include SwissProt functional information, GeneOntology annotations, Links to 
outside database such as LocusLink and UCSC Genome Browser, chromosomal 
location, the LocusLink descriptive summary, Aliases, and a link to Source’s 
microarray gene expression data (http://source.stanford.edu/cgi-bin/sourceSearch). 
 
3.2 Genome analysis and annotation 
The standard steps involved in the structure-function annotation of uncharacterized 
proteins include (1) sequence similarity searches using programs such as BLAST, 
FASTA; (2) identifying functional motifs and structural domains by comparing the 
protein sequence against PROSITE, BLOCKS, SMART, or Pfam; (3) predicted 
structural features of the protein, such as likely signal peptides, transmembrane 
segments, coiled-coil regions, and other regions of low sequence complexity; and (4) 
generating a secondary, and if possible tertiary, structure prediction. 
 
Comparative analyses of several bacterial, archaeal, and eukaryotic genomes showed 
that the sequence comparison methods mentioned above failed to predict protein 
function for at least one-third of gene products in any given genome. In these cases, 
other approaches can be used that take into consideration all other available data, 
putting them into “genome context” (Huynen and Snel, 2000). With the availability of 
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multiple complete genomes, the comparative approach is becoming the most powerful 
strategy for genome analysis. 
 
It has been proposed that using association analysis of single nucleotide 
polymorphism (SNP) markers in candidate genes may be useful in identifying disease 
susceptibility genes for complex diseases. SNPs are plentiful throughout the human 
genome, being found in exons, introns, promoters, enhancers, and intergenic regions, 
allowing them to be used as markers. The next section provides insights into the SNPs 
and association studies. 
 
4.      SNPs as genetic markers 
The focus in recent years on single nucleotide polymorphisms (SNPs), as initiated by 
groups such as the SNP Consortium and the U.S. National Human Genome Research 
Institute (NHGRI), has recognized that these single-base variations could enable 
novel approaches for elucidating complex, polygenic diseases, and potentially lead to 
the identification of new drug targets and diagnostic tests. Occurring on average once 
every 1000 bases along the human genome, SNPs might act as genetic markers linked 
to disease susceptibility genes, and coding SNPs in genes or control regions might 
even directly influence susceptibility to cancer, heart disease, diabetes, and other 
common diseases. In the postgenomics era, the focus has shifted to high-throughput 
studies intended to elucidate how genomic differences between individuals relate to 
their predisposition to disease, and how best to diagnose and treat those individuals 
with specific reference to their individual genetic makeup.  
 
4.1 SNPs and association studies 
Association studies have recently received a great deal of attention as a tool for 
detecting the genetic variation responsible for human common diseases. Unlike 
traditional linkage studies, which uses recombination information in large pedigrees, 
association methods use recombination information at the population level. Thus, 
association methods have greater power to detect small and moderate genetic effects 
than does linkage analysis (Risch and Merikangas, 1996). SNP markers are preferred 
over microsatellite markers for association studies, because of their high abundance 
along the human genome (SNPs with minor allele frequency >0.1 occur once every 
600 bp) (Wang et al., 1998),  their low mutation rate, and the accessibility of high-
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throughput genotyping. The power of association studies based on SNPs depends not 
only on the sample size and density of the marker map but also on many other factors, 
such as the age and frequency of the disease mutations and SNPs and the extent of 
linkage disequilibrium (LD) in the region. 
 
4.2 Haplotype blocks and haplotype tag SNPs 
Recent studies have shown that the human genome can be partitioned into blocks with 
limited haplotype diversity (Daly et al., 2001; Johnson et al., 2001; Patil et al., 2001; 
Dawson et al., 2002; Gabriel et al., 2002). In each block, a small fraction of single-
nucleotide polymorphisms (SNPs), referred to as " haplotype tag SNPs (htSNPs)," can 
be used to distinguish a large fraction of the haplotypes. These tag SNPs can 
potentially be useful for association studies, in that it may not be necessary to 
genotype all SNPs in a given interval (Johnson et al., 2001). 
Haplotype blocks, together with the corresponding htSNPs and common haplotypes 
determined by haplotype block partitioning algorithms, can be used in genome wide 
association studies, as well as in the fine-scale mapping of complex disease genes. 
First, a small number of samples (e.g., 10 or 20 individuals) are chosen to be 
genotyped for a dense SNP map in a region, and the haplotypes of these individuals 
are identified simultaneously. Second, an algorithm for haplotype block partitioning is 
employed, to identify haplotype block structure and the htSNPs based on the 
genotypes of the sampled individuals. Third, a larger number of samples (patients and 
controls) are genotyped only at these htSNP marker loci. Fourth, association studies 
are conducted using all the genotyped samples, with knowledge of the haplotype 
block structure. It seems that the above approach can significantly reduce the 
genotyping costs (Johnson et al., 2001). 
 
4.3 Identification of new polymorphisms 
A variety of techniques are available for the identification of new polymorphisms. 
One commonly used approach for SNP screening is to amplify genes of interest by 
PCR, scan the PCR products for the presence of DNA variants by confirmation-based 
mutation scanning methods, and then sequence positive PCR products. With a vast 
amount of human ESTs and genomic clones in the public domain, computer-based 
sequence alignment and clustering also provide a rich source for SNP identification. 
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Single-strand conformation polymorphism (SSCP) (Orita et al., 1989) analysis is one 
of the most widely used methods for mutation detection. In SSCP, DNA regions with 
potential polymorphisms are first amplified by PCR. Single-stranded DNAs are then 
generated by denaturation of the PCR products and separated on a nondenaturing 
polyacrylamide gel. A fragment with a single base modification generally forms a 
different conformer and migrates differently when compared with wild-type DNA. 
 
Other alternative conformation-based mutation screening methods include denaturing 
high performance liquid chromatography (DHPLC) (O'Donovan et al., 1998). 
DHPLC detects polymorphisms by analyzing the DNA mobility of different 
heteroduplexes using chromatography in a slightly denaturing condition. The 
WAVE® DNA analysis system from Transgenomic, Inc. (San Jose, CA, USA) uses 
temperature-modulated hereroduplex analysis. The sample first is hybridized with 
wild-type DNA to form a mixture of homo- and heteroduplexes. The heteroduplexes 
can be separated from the homoduplexes by column chromatography at a temperature 
that partially denatures the mismatched DNA. The first gene subjected to dHPLC 
analysis was the calcium channel gene CACNL1A4 (Ophoff et al., 1996). Since then, 
more than hundred genes have been analysed. 
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II OUTLINE OF THE PRESENT RESEARCH 
The goal of this project was to systematically identify and characterize genes 
expressed exclusively or abundantly in the RPE and to assess their contribution to 
AMD. The work described in this thesis is essentially interdisciplinary in nature in 
that, while the basic subject matter is biological and results of biological interest are 
obtained, techniques from other fields are used, including bioinformatic and computer 
tools. The aims of the present study were five-fold. Firstly, to analyse the domain of 
the project using standard systems analysis and design techniques to compile a 
suitable requirements specification for the design of a system. To assess the 
commercial database management systems (DBMSs) available and their suitability to 
the current project in order to select one. To construct a prototype of the system and 
test it. The system should have functions covering issue for clone, gene, expression, 
function, and to keep track of the status of searches similarity.  
 
Secondly, to analyze and querry the individual of 2379 cDNA sequences derived from 
the suppression subtractive RPE (SSRPE) cNDA library against sequences deposited 
in GenBank and dbEST databases. In addition, storage and maintainace of the blast 
searches in the constructed relational database management system (RDBMS). A 
powerful approach to the analysis of expression in the RPE involves single-pass 
partial sequencing of clones from the SSRPE cDNA library together with the 
comparative analysis of the resuling ESTs with entries in public databases. This 
process leads to the establishment of a comprehensive catalogue of RPE-derived 
ESTs.  
 
Thirdly, to carry out in silico expression and functional profiling of known and 
predicted RPE genes that identified during the course of this study.  
 
Fourthly, to characterize the full-length cDNA sequences for 1-2 human orthologous 
RPE and/or retina genes.  
 
Finally, generation of a SNP map for RPE01-D2 that will facilitate future association 
studies. SNP mapping conducts using a combination of DHPLC and direct 
sequencing.  
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III MATERIALS AND METHODS 
1. cDNA library construction 
The suppression subtractive hybridization (SSH) method was adapted to generate a 
cDNA library highly enriched for differentially expressed bovine RPE transcripts. A 
suppression subtractive RPE (SSRPE) cDNA library was performed in-house by 
Andrea Gerhig using a PCR-Select cDNA Subtraction kit (Clontech) according to the 
manufacturer's protocol (for review see Diatchenko et al. 1996 and 1999). In brief, 
tester cDNA was isolated from 50 ng bovine RPE poly(A)+ RNA using SMART PCR 
cDNA synthesis kit (Clontech), and driver cDNA was prepared from an equal 
proporation of 150 ng bovine poly(A) RNA of heart and liver. A modified random 3’ 
SMART CDS primer II (5′-AGCAGTGGTAACAACGCAGAGTACNNNNNNT 
GTGG-3′) was used for the first-strand synthesis reaction. The SMART II A 
Oligonucleotide (5′-AAGCAGTGGTATCAACGCAGAGTACGCGGG-3′), which 
has an oligo (G) sequence at its 3′ end, base pairs with the deoxycytidine stretch, 
creating an extended template. Reverse transcriptase (RT) switches templates and 
continues replicating to the end of the oligonucleotide. The cDNA was then amplified 
by long distance polymerase chain reaction (LD-PCR) using 5′ PCR primer II A (5′ 
AAGCAGTGGTATCAACGCAGAGT 3′). 
 
Both tester and driver cDNAs were separately digested with RsaI to obtain shorter, 
blunt-ended molecules. Tester fragments were divided into two samples and ligated 
with two different adaptors; adaptor 1 (5′-CTAATACGACTCACTATAGGGCTCG 
AGCGGCCGCCCGGGCAGGT-3′) and adaptor 2R (5′-CTAATACGACTCACTAT 
A GGGCAGCGTGGTCGCGGCCGAG GT-3′). Each ligated tester sample was then 
hybridized with an excess of driver cDNA. The hybridized samples were mixed, and a 
second round of hybridization was performed with excess driver, followed by two 
rounds of PCR resulting in exponential amplification of the differentially expressed 
sequences. The PCR products were analyzed by agarose gel electrophoresis. Products 
from the secondary PCRs were ligated into pCRII vector using a TA cloning kit 
(Invitrogen), and transformed into TOP10F one shot competent cells, and selected by 
blue/white screening. 
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A total of 2379 independent cDNA clones (1002 in-house and 1377 by Lynkeus 
Biotech, Wuerzburg, Germany) were picked randomly, inoculated directly into 96-
well microtitre plates containing 100 µl Luria-Bertani (LB) broth with ampicilin (50 
µg/ml) and cultured overnight at 37 oC. These plates were then stored at – 80oC for 
further analysis. 
 
2. EST amplification and sequencing 
Plasmid DNA was used as a template for PCR amplification of the clones using the 
vector M13 forward primer (5′-CGCCAGGGTTTTCCCAGTCACGAC-3′) and M13 
reverse primer (5′-AGCGGATAACAATTTCACACAGGA-3′). Briefly, PCRs were 
performed in a 25 µl reaction consisting of 2µl plasmid DNA (10-100 ng); 10 pmol of 
each M13 forward and M13 reverse primer; 1.25 mM dNTPs; 1 unit Taq DNA 
polymerase; 1 X PCR buffer; 1.0 or 1.5 mM MgCl2. Thermal cycling was as follows: 
94° C/5 min; 29 cycles of 94° C/30 sec; 65° C/30 sec; 72° C/1 min and a final 
extension at 72° C/5 min. After the PCR amplification, 5µl of the products were 
analysed in a 1% agarose gel. Because the RPE subtracted library was non-
directionally cloned, the 2379 RPE ESTs were generated from either the 5′ or the 3′ 
end of the cDNA clones using nested primers either PCRII forward (5′-
CTCGGATCCACTAGTAACGG-3′) or PCRII reverse (5′GCCGCCAGTGTGA 
TGGATAT-3′). The sequencing was conducted using the ABI Prism Ready Reaction 
Sequencing Kit and the ABI 310 automated sequencer (Perkin-Elmer, Norwalk, 
USA).  
 
3. Bioinformatics 
3.1 Design and Implementation of a Relational Database Management 
System (DBMS) 
 
To store and manipulate the data a commercial relational database management 
system (RDBMS) and especially Microsoft Access was used. The optimized and 
efficient database engine of a commercial RDBMS makes the system modular and 
versatile. The SSRPE cDNA library information may be easily translated into 
normalized relational tables. Structured query language (SQL) statements and 
operations may be used to query these tables and derive composite information. This 
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type of data storage scheme creates an extremely robust and efficient data repository 
that can be extended almost indefinitely. 
 
3.1.1  Structured Systems Analysis and Design Method (SSADM) 
The Structured Systems Analysis and Design Method (SSADM) is the most 
comprehensive of structured development methods currently available. It provides a 
framework and specific techniques to drive the process of computer systems 
specification and design (Meldrum et al., 1993). SSADM is designed to support the 
building of information systems, i.e. systems which have an underlying repository of 
data which must be accessed and updated. Logical Data Modelling (LDM) and 
Relational Data Analysis (RDA) are two of the central techniques of SSADM. LDM 
is used to define the data requirements for an application and consequently assumes a 
critical role in SSADM. RDA, also referred to as Third Normal Form Analysis, is 
used to validate the LDM. By applying the two techniques of LDM and RDA, 
SSADM ensures that the resultant data model is devoid of any unnecessary data 
duplications and thus supports system processing in an efficient and flexible manner. 
Both LDM and RDA are used in designing the RDBMS for the current project.  
 
3.1.2  Logical Data Modelling (LDM) 
The LDM is termed “logical” in that it models the underlying data requirements of an 
application regardless of how data will be processed and stored. LDM consists of a 
diagram (called the Logical Data Structure) with supporting textual definitions. The 
model defines the data requirements for an application by means of two key concepts: 
the entities (or groupings or data) inherent in the application; and the relationships (or 
associations) between the entities. 
 
An entity represents a concept, object or thing which is relevant to the application 
being developed and about which information needs to be held by the application. 
Each of which needs to be individually identified by a unique reference or “key”. For 
example, a Clone processing application will probably have entities such as CLONE 
(identified by a key of Clone Name or ID) and GENE (identified by a key of Gene 
symbol or ID). An entity is represented on the Logical Data Structure using box with 
its name (in singular) appears inside the box. 
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Each entity consists of a grouping of attributes (or data items), which together provide 
a detailed definition of the object or concept represented by the entity. During design 
phase of the application development process, entities will be used to derive the 
groupings of data which will be physically stored e.g. tables, record tpyes, and files. 
For example, for the current RDBMS, it is likely that the “objects” about which data 
needs to be held will include: Clone, Gene, Clone – Gene, Exon, Category, Contig, 
Expression and Function. 
 
Some attributes may appear in more than one entity, where an attribute is a foreign 
key or where the attribute is assuming a different role. However, it is widely 
recommended when considering and examining entities, to identify the attributes 
which comprise the entity. If no attributes can be identified, the validity of the entity 
may be in doubt. 
 
An entity is deemed to contain a foreign key if it contains the primary key of another 
entity, provided this foreign key does not form part of the entity’s own primary key. A 
foreign key means that there is a relationship between the entity containing the 
foreign key and the entity for which the foreign key is the primary key. The entity 
containing the foreign key is the “Detail” entity in the relationship. Whereas, the 
entity for which the foreign key is the primary key is the “Master” entity. In the 
following example, entity Clone-Gene contains a foreign key to entity category: 
 
Category    Clone - Gene
Category ID   Clone ID   
Category name   Gene ID 
Contig ID 
*Category ID 
Library type 
Search similarity 
      
Foreign keys are sometimes denoted by placing a marker usually an asterisk – against 
them. 
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A relationship represents an association between two entities which is of importance 
to the application being developed. It is critical that relationships are carefully and 
fully documented as they will be used, during design, to derive the access 
mechanisms which are implemented to retrieve the physically stored data. To identify 
the relationships, each pair of entities must be checked for the possibilty of the 
existence of a relationship. When a relationship has been identified, the degree of the 
relationship should be established. Most relationships will be one-to-many (1:M) or 
many-to-one (M:1). One-to-one (1:1) and many-to-many (N:M) relationships may 
appear at this stage of design, but they should be resolved later by the addition of link 
entities. If a one-to-one relationship is identified it should be examined closely to see 
if the two entities can be combined. There are few cases where a 1:1 relationship can 
exist if the two entities have different keys, different lives and are governed by 
different time periods. Many-to-many relationships are not permitted in SSADM, they 
contradict the Master/Detail concept. 
 
3.1.3    Relational Data Analysis (RDA) 
The Relational Data Analysis (RDA) with its emphasis on the detailed analysis of 
data  will tend to produce data structures which are large, complex and devoid of any 
data duplication. Compared to the RDA data structure, LDM tends to produce data 
structures which are smaller (i.e. fewer entities), simpler (few relationships) and more 
tuned to the system’s processing requirements (Meldrum et al., 1993). However, 
because of this, the LDM may contain data duplication and may be less flexible in 
accommodating any future changes to system processing. 
 
A relation is a grouping of logically-related attributes. The aim of RDA is to produce 
relations which are in Third Normal Form (TNF). Relations in TNF are devoid of any 
data duplication and represent the most optimum groupings of attributes for storage 
purposes. The underlying concept behind a relation is that data can be represented by 
means of a two dimensional table, comprising a number of rows and a number of 
columns (Table 2). Each column of the table is an attribute of relation (similar in 
concept to an attribute of an entity) and each row of the table represents an occurrence 
of the relation (similar in concept to the occurrence of an entity). An example of a 
relation holding clone details is shown in Table 2. 
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Table 2 Clone relation 
Clone_Name Clone_sequence Clone_length Clone_organism Clone_Tissue
RPE03-D12 AGCGTGGTCGCGGCCGA
GGTACCTCC 
594 Bos taurus RPE 
RPE20-A12 GGAGAGCTCCCAACGCG
TTGGATGCA 
371 Bos taurus RPE 
RPE01-B01 TAGCGTGGTCNGCGGCC
GAGGTACTT 
548 Bos taurus RPE 
RPE20-B03 TAGCGTGGTCGCGGCCG
AGGTACCG 
363 Bos taurus RPE 
RPE03-B07 TCGAGCGGCCGCCCGG
GCAGGTACC 
571 Bos taurus RPE 
RPE08-C04 TTAGCGTGGTCGCGGCC
GAGGTACTT 
591 Bos taurus RPE 
 
 
The values for each row in a relation must be different to that of any other row. While 
it is likely that different rows will have the same values for particular columns, no two 
rows can have the same values for all columns. In the clone relation above, while the 
values of certain columns are the same for particular rows (i.e. clone organism and 
clone tissue), each row is different from all others (Table 2). Rather than show 
relations as table, the name of each relation is given, followed by a list of the 
attributes (i.e. column names) comprising the relation. Just as each occurrence of an 
entity is identified by means of the primary key, each row of a relation must also be 
uniquely identified by means of a primary key, which will consist of a single or set of 
column values. The primary key of a relation is denoted by underlining the relevant 
attribute(s) and placing it (them) at the top of the list of attributes. 
 
 Relation:  Clone 
 Clone Name 
 Clone Sequence 
 Clone Length 
 Clone Organim 
 Clone Tissue 
 
In RDA, normalisation is the process of producing a data structure containing the 
optimum grouping of attributes. An attribute is deemed to be “dependent” on the 
primary key if the value of the attribute can only be determined if the value of the key 
is known. To start the RDA process, the source material must be identified. The 
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source material will be derived from the inputs and outputs of the required system. 
The next step is the conversion of the source data into Un-Normalised Form by listing 
all the attributes contained in the RDA source, as well as identifying the key of the 
Un-normalised relation. The RDA source must be analysed to identify all attributes 
contained within the source. When identifying the attributes on an RDA source, 
attributes which can be derived from other attributes on the source can usually be 
ignored.  
 
The data model derived from the RDA is compared with the LDM. Any discrepancies 
between the two models must be considered with the objective of identifying any 
changes to the LDM which are needed to reflect the optimum grouping of attributes 
resulting from the RDA technique. 
 
3.1.4     Physical Database Construction (MS Access) 
This represents the last phase of database design and involves actually building the 
tables and relationships into the database (in this case MS Access). The process of 
physical database construction simply involves converting the logical database design 
into actucal tables, and determination of what data types will be used for specific 
attributes. Microsoft Access is a relational database management system (RDBMS). 
RDBMS is a program that facilitates the storage and retrieval of structured 
information on a computer’s hard drive.  
 
In general, there are two basic approaches to developing information systems, first 
approach involves in-depth system analysis, design, and implementation. The second 
approach is done using rapid prototyping (in which analysis, design, and 
implementation are done iteratively). MS Access provides a number of features (such 
as graphical design tools, wizards, and high-level macro language) that facilitate rapid 
prototyping. Access application is a database that contains all objects necessary for 
users to work with data, as well as specific property settings and macros that automate 
data entry tasks. One of the well-known characteristic features of MS Access is the 
objects. Objects within the database, such as tables, queries, forms and reports (Table 
3), are modified through their property settings to guide a user through completion of 
database tasks. Macros and Visual Basic procedures can automate the database so that 
forms and reports are displayed when needed. In addition, SQL can be used to 
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construct queries that are then executed against a database, the result being a 
recordset.  SQL is a standard language that can be used in a variety of databases, not 
just Access, with some minor modifications needed for each database program. The 
four most important SQL statements are SELECT, DELETE, INSERT, and UPDATE 
and they all are supported in Access. 
 
Table 3 MS Access Objects and their functions 
 
Object   Function 
 
Table     used to store data.  
 
Query    used to retrieve specific information from a table. 
 
Form    used to enter data into a table in a database, also  
used to view and modify data. 
 
Report    used for displaying and printing data in an easy- 
to-read format. 
 
Page    used to show data on the Internet. 
 
Macro    used to automate frequently performed database  
tasks. 
 
Module   a program written in Visual Basic to automate  
and customize database operations. 
 
 
3.2 BLAST searches 
Before being assembled into clusters, sequences corresponding to the vector and the 
nested primers used to construct the SSRPE cDNA library were removed from each 
clone. This resulted in ESTs of approximately 300-600 bp of high quality sequence. 
Contig assembly program CAP3 (Huang and Madan, 1999) was used to assemble the 
high quality sequences into clusters and singletons. Nucleotide and protein BLAST 
programs at the National Center for Biotechnology Information - NCBI (http:// 
www.ncbi.nlm.nih.gov/BLAST/) were used for sequence homology searches in public 
databases. Annotations of possible protein-coding genes were performed and recorded 
in the constructed RDBMS for further investigations.  
A first sequence search was conducted using BlastN against all entries in the non-
redundant GenBank database. Sequences with E-values expected equaling zero were 
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considered to identify known genes or to have partial similarity to known genes. 
Sequences with E-value close to zero were analysed for overall similarity that could 
be a different gene from the same family, chimeric clones, alternative splicing or 
presence of vector sequences. Sequences including repetitive fragments (e.g., LINE, 
ALU) were considered after eliminating the repetitive fragments and the Blast 
searches of non-repetitive part of sequences revealed an E-value equal to zero. The 
sequences that showed no match in the non-redundant database were subjected to 
another search with the BlastN against the dbEST and HTGs database. A second 
sequence search using normalized transcripts was performed using BlastN against the 
human genome draft sequence (http://www.ncbi.nlm.nih.gov/genome/seq/page.cgi?F            
=HsBlast.html&&ORG=Hs). The BLAST parameters used were as follows: Blastn 
program with an expect value of IE-50, default filter, and the default for the penality 
for a nucleotide mismatch is “-q –3”. But, in the present study a penality for a 
nucleotide mismatch of “-q –1” was used to increase the homology in our cross 
species comparisons.  
Clones showing high homology with previously described sequences were considered 
to represent known genes. Clones with high homology with more than one gene were 
identified on the basis of highest homology of human origin. ESTs for which no 
homology was found were considered unknown. 
Functional classification of the RPE known genes was undertaken by using the 
LocusLink, GeneOntology and Source database. Additionally, functional 
classification of the genes was based on the primary reported function obtained from 
the PubMed literature (http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?                 
CMD=search&DB=PubMed). Domain searches were performed using Pfam at 
Washington University in St. Louis public online search tools 
(http://pfam.wustl.edu/). 
 
4. Identification and characterization of genes 
4.1 RNA extraction and first strand cDNA synthesis 
The RNA Clean system (Hybaid) was used to extract total RNA from frozen samples 
of human heart, brain, retina, RPE, lung, and placenta tissue. Residual genomic DNA 
was removed by the DNA free kit (Ambion). For RT-PCR experiments, 1–2 µg of 
total RNA was reverse transcribed using the SuperscriptTM preamplification system 
according to the supplier’s protocol (Gibco-BRL, Karlsruhe, Germany), and then used 
                                                                                                                   Materials and Methods    
 
35
as a template for PCR. First cDNA strands were synthesized in 20µl reaction mixtures 
as follows: 
1 µl Oligo-(dT)12-18 [500µg/ml] 
1-5 µg total RNA 
up 12 µl DEPC-H2O 
1µl 10 mM dNTP-Mix [each 10 mM dATP, dCTP dGTP, dTTP] 
 
The reaction was incubated at 70°C for 15 minutes and then put on ice for 5 minutes. 
The following reagents were added: 
4µl 5×1st strand buffer [250mM Tris-HCl, pH 8.3; 375 mM KCl, 15mM MgCl2] 
2µl 0.1M DTT  
1µl SuperScript™ II [200U] 
Samples were incubated at 42°C for 52 minute, and were then inactivated by heating 
at 70°C for 15 minutes.  
 
To normalize for variations in the amount of input RNA and synthesized cDNA from 
each tissue, routine control PCR reactions were conducted on 1 µl of newly 
synthesized first-strand cDNA with two different primer pairs amplifying the 
housekeeping gene ß-glucuronidase (GUSB). Due to its ubiquitious expression at low 
levels (Bracey and Paigen, 1987), GUSB was used for standardization of the cDNA 
targets. Oligonucleotides GUSB3 (5′-ACTATCGCCATCAACAACACACTGACC-
3′) and GUSB4R (5′-GTGACGGTGATGTCATCGAT-3′) amplify a 198-bp fragment 
in cDNA and a 376-bp fragment in genomic DNA spanning exons 3 to 4. 
Amplification with GUSB6F (5′-GATCCACCTCTGATGTTCAC-3′) and GUSB7R 
(5′-CCTTTAGTGTTCCCTGCTAG-3′) results in a 454-bp fragment in cDNA 
spanning exon 11 and exon 12. Genomic DNA is not amplified due to a large 
intervening sequences of about 13 kb (Miller et al., 1990). 5 µl of the PCR reactions 
were electrophoretically separated on a 1% agarose gel stained with ethidium bromide 
and the band intensities were compared.  
 
4.2 Polymerase Chain Reaction (PCR) 
Specific primer pairs were designed using the DOS-based Oligo version 2.0 (NAR) 
program (Rychlik and Rhoads, 1989) and confirmed by employing the Primer3 
program available at http://www-genome.wi.mit.edu/cgi-bin/primer/primer3 for the 
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amplification of the desired DNA or cDNA fragment. The PCR reactions were carried 
out as described (Saiki et al., 1988) in a 25 µl reaction mixture containing 50 ng of 
template DNA and 10 pmol of each primer, 1.25 mM of dNTPs, 1 U of Taq DNA 
polymerase, 1 × PCR buffer; 1.0 or 1.5 mM MgCl2. Samples were denatured at 94° C 
for 5 min,  and 30 cycles were performed as follows: denaturing at 94° C for 30 sec, 
annealing for 1 min at a temperature dependent upon the specific primer pair, 
elongation at 72° C for 1 min, followed by another elongation for 5 min. Then 5 µl 
samples were loaded on 1% agarose gels stained with ethidium bromide, and finally 
the DNA was made visible under UV light. 
The annealing temperature Tm can be determined experimentally but is usually 
calculated applying the simple formula: 
 
  Tm  = (4 X (G + C) + (2 X (A + T) °C 
 
in which (G + C) is the number of G and C nucleotides in the primer sequence, and (A 
+ T) is the number of A and T nucleotides. The annealing temperature for a PCR 
experiment is determined by calculating the Tm for each primer and using a 
temperature 1- 5 °C below this number. 
 
4.2.1 PCRx Enhancer solution 
The PCRx Enhancer system (Invitrogen) is an optimized buffer and cosolvent system 
that simplifies PCR amplification of problematic and/or GC rich templates. For 
example, the clone RPE06-C10 was found to show similarity to a single-exon gene 
that is not annotated in the Human Genome Sequence draft (Build 33). This intronless 
gene is located in a GC-rich region. GC rich regions can be extremely difficult to 
amplify and sequence. RPE06-C10 was amplified using 2X PCRx Enhancer solution 
using 3 pair of primers (RPE06-C10F1 5′-CTGACCCCTCTTGCCCCC-3′; RPE06-
C10R1 5′-CGCCGTCCTCCACCACCT-3′; RPE06-C10F2 5′-GCCTCACGCA 
CAACCACATC-3′; RPE06-C10R2 5′- TAGCGGTAGTGGTAGCCCTCC  -3′; 
RPE06 -C10F3 5′-GTGCTCTACCTAAACCGCCG-3′; RPE06-C10R3 5′-GCTCTG 
GGATGGGACAAAGG-3′) that were designed in an overlapping manner to cover the 
entire length of the single-exon gene. 
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4.3 Reverse Transcriptase (RT) PCR 
RT-PCR is conducting using standard PCR (4.2) and first strand cDNA (4.1) as 
template and forward and reverse primers. Oligonucleotide RPE01-D2F(5′GCAGCA 
AAA GCAACAGCAGC-3′) and RPE01-D2R (5′-TCAGAGCAGGCAGGATTCGC-
3′) and first strand retina cDNA were used to RT-PCR amplify the RPE01-D2. 
 
 4.4 Northern blotting 
The Oligotex kit (Qiagen) was used to extract total RNA from frozen samples of 
bovine heart, liver, brain, retinal pigment epithelium, kidney and lung tissue. The 
RNA preparation was done under sterile and Rnase-free conditions. Residual genomic 
DNA was removed by the DNA-free kit (Ambion). 
Norhtern blot analysis was performed with 7 µg of total RNA from bovine heart, 
liver, brain, retina, RPE, kidney and lung electrophoretically separated in the presence 
of formaldehyde at 55-75 Voltage for 3 hours. 10 X MOPS buffer (0.2  M MOPS, 50 
mM NaOAc, 10 mM Na2 EDTA; pH 7.0) is used as electrophoresis buffer.  7 µg 
RNA (relevant tissue quantity) and 12 µl loading buffer (1 X MOPS, 18.5 
formaldehyde, 50% formamide, 0.04% bromphenol blue, 10 µg ethidiume bromide) are 
mixed and denatured for 10 min at 65°C. Total RNA is vacuum transferred to 
Hybond-N+ membranes (Amersham Pharmacia Biotech, Freiburg, Germany) in 20 X 
SSC buffer (3 M NaCl, 0.3 M sodium citrate; pH 7.0). 
Selective individual clones of the SSRPE cDNA library were used as probes. The 
probes were purified and labeled with α32 P-dCTP by nick translation (Nick 
Translation System, Gibco BRL) according to the manufacturer’s protocol. The filters 
were hybridized overnight in 0.5 mM sodium phosphate buffer, pH 7.2; 7% SDS, 1 
mM EDTA at 600 C. The hybridization buffer was removed and the filter was washed 
with washing buffer at 600 C for 15 min in 2X SSPE/0.1% SDS, 1X SSPE/0.1% SDS 
and 0.5 X SSPE/0.1% SDS (20 X SSPE: 3 M NaCl, 200 mM NaH2PO4, 20 mM Na2 
EDTA). The filters were wrapped with prafan membrane and exposed to a X-rays 
films at –800 C for 3 – 5 days. 
 
4.5 Cloning of PCR products for RPE01-D2 
The PCR products were ligated into pGEM® T-easy vector (Promega) and then transformed 
into E. Coli according to the manufacturer's protocol. 
                                                                                                                   Materials and Methods    
 
38
The LB medium and SOC were prepared as follows: 
 LB medium (per liter) 
  10g Bacto®-Tryptone 
   5g Bacto®-Yeast Extract 
   5g NaCl 
  The pH was adjusted to 7.0 with NaOH 
 SOC medium (100 ml) 
  2g Bacto®-Tryptone 
  0.5g Bacto®-Yeast Extract 
   1ml NaCl 
  0.25ml 1M KCl 
  1ml 2M Mg2+ stock, filter sterilized 
  1ml 2M glucose, filter sterilized 
 
15g of agar was added to 1 liter of LB medium and then autoclaved. The medium was 
allowed to cool to 50°C before adding ampicillin to a final concentration of 100µg/ml. 
30-35ml of the medium was poured into 85mm petri dishes. The agar was left to be 
hardened. The medium was stored at room temperature.  
 
4.5.1 Ligation of RPE01-D2  
The ligation reaction in a final volume of 10 µl was set up in 0.5ml tube (known to 
have low DNA-binding capacity) as follows: 
5 µl 2 X Rapid ligation Buffer (it is important to vortex)  
1 µl pGEM-T Easy Vector (50ng) 
1 µl T4 DNA ligase 
3 µl PCR product 
The reaction was mixed by pipetting and then incubated overnight at 4°C. 
 
4.5.2 Transformation of the ligated RPE01-D2 
The tube containing the ligation reaction was centrifuged to collect contents at the 
bottom of the tube. 1µl of ligated DNA was added to the sterile 1.5ml microcentrifuge 
tube containing the thawed competent cells (JM109) on ice. The contents of the 1.5ml 
tube were put into cuvette tube. The cuvette was then put in the gene pulser (BIO-
RAD), which was already turned on and adjusted to 2.50. The cells were heat shocked 
inside the cuvette by pressing the two buttons of the gene pluser until a sound was 
heard.  500µl of SOC medium was added to the cuvette tube. The contents of the 
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cuvette tube were then transferred into 1.5ml tube. The 1.5ml tube was incubated for 
1 hour at 37°C. Prior to plating, 20µl of 50mg/ml X-Gal and 100µl of 100mM IPTG 
were added to 2 LB/ampicilin plates. 100µl of transformation culture was plated onto 
the duplicate LB/ampicilin/IPTG/X-Gal plates. The plates were incubated overnight at 
37°C. The unused portion of the transformation culture was stored at 4°C. Using 
blue/white screening, positive clones were recognized and selected. 30 0.5ml tubes 
were prepared with the mix of 20µl (4µl ampicilin+1ml LB medium). Each of the 
0.5ml tube was innoculated with a colony. The 30 tubes (clone1 to clone30) were then 
incubated either at 37°C for 3 hours or overnight at room temperature.  
 
4.5.3   Clones amplification and sequencing 
PCR amplification of clones from Plasmid DNA was done using either the gene 
specific primers (GSP) RPE01-D2F and RPE01-D2R or the vector M13 forward 
primer and M13 reverse primer. 5 µl of the PCR products were separated by gel 
electrophoresis and visualized under UV illumination. PCR products showing inserts 
were treated with shrimp alkaline phosphatase (USB, Cleveland, USA) and 
exonuclease I (USB, Cleveland, USA) and then sequenced using the ABI Prism 
Ready Reaction Sequencing Kit and the ABI 310 automated sequencer (Perkin-Elmer, 
Norwalk, USA).  
 
5. SNP genotyping 
The genomic sequence as well as 5 kb upstream and downstream of the RPE01-D2 
(official nomenclature RDH12) gene were downloaded from the NCBI Blast. The 
repeat mask web server program (http://repeatmasker.genome.washington.edu/cgi-
bin/RepeatMasker), was used to determine the repeat regions of the genomic sequence 
of the RDH12 gene.  The primers were designed to flank 25 fragments of the gene, 
using the DOS-based Oligo version 2.0 (NAR) program (Rychlik and Rhoads, 1989) 
and a web-based primer3 (http://www-genome.wi.mit.edu/cgi-bin/primer/primer3 
www.cgi/). 
 
5.1 SNPs identification  
A combination of denaturing high performance liquid chromatography (DHPLC) 
(O'Donovan et al., 1998) and direct DNA sequencing were used to screen the RDH12 
gene for single nucleotide polymphism (SNP). The genomic DNA was isolated from 
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peripheral blood leukocytes of 16 control DNAs according to standard protocols. The 
DNA controls from 16 individuals were used to PCR amplify the 25 fragments of the 
RDH12 gene. The individual coding exons, flanking intronic sequences as well as the 
5′ and 3′ untranslated regions (UTR) of the RDH12 gene were PCR amplified with the 
oligonucleotide primers and conditions listed in Table 4. Reactions were conducted 
for 33 cycles in 1.0 or 1.5 mM MgCl2 containing buffer with or without 4% 
formamide and a touch-down protocol between 58° and 52°C (Table 4). 
DHPLC analysis was performed on a Wave DNA Fragment Analysis System 
(Transgenomic Inc., Omaha, USA) In brief, 5-10 µl of the PCR products were 
denatured at 95°C for 5 min and cooled down to 65°C with a temperature ramp of 
1°C/min to produce heteroduplex molecules in case of heterozygous DNA samples. 
DNA was eluted at a flow rate of 0.9 ml/min within a linear acetonitrile gradient 
consisting of buffer A (0.1 M triethylammonium acetate, TEAA) and buffer B (0.1 M 
TEAA, and 25% acetonitrile). Temperature selection for the successful heteroduplex 
separation in heterozygous fragments was carried out using the WaveMaker software 
(Transgenomic) typically within the range of 54 to 68°C. To identify homozygous 
mutations, aliquots of a known wild-type sample were added to the DNA prior to the 
re-annealing step to enable heteroduplex formation. The average analysis time per 
sample took 8-12 min including a regeneration and equilibration step. The linear 
acetonitrile gradient was adjusted to a retention time of the DNA peak at 4-5 min. 
PCR products with heteroduplex formation were subjected to sequence analysis in 
order to reveal the nature of the polymorphism. 
 
5.2 Determination of allele frequency of the identified SNPs 
The fragments that showed significant SNP frequency equal to or more than 20%, 
were then PCR amplified from 48 family DNA controls, purified and then were 
sequenced at MWG (MWG Biotech, München, Germany). The SeqMan™ II software 
(DNASTAR Inc., 1989-2002) (http://www.dnastar.com/cgi-bin/php.cgi? r13.php)  
was used to align the sequences of the 48 DNA controls to determine the allele 
frequency for each identified SNPs. As a result of this, a SNP card was prepared for 
the RDH12 gene, showing all the SNPs identified during the process of SNP mapping. 
Using the SNP card, the SNPs that are running together were determined from the 48 
family DNA controls. These SNPs are in strong linkage disequilibium. 
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Table 4  Oligonucleotide primers and conditions of SNP genotyping for RDH12 
Fragment Primer    Primer   ANNEALING            MgCl2
number  name    sequence (5′- 3′)  TEMPERATURE   mM*  
                    °C                                                                               
1  ID2-5’UTR-F1 TGTCAATAGTGCCTGCTGTG       
  ID2-5’UTR-R1 CTTGCTGATTTGACCTTTGG                 52                    1.0- 
 
2  ID2-5’UTR-F2 AGGGATAACCAGGAGACCAG       
  ID2-5’UTR-R2 CATCACCCACTTCATCATTGT               55    1.0- 
 
3  ID2-5’UTR-F3 TTATGGCTTTGCTTATGTGC                  
  ID2-5’UTR-R3 GCAAAAAGACCCTGATAACC                58  1.0- 
 
4  ID2-5’UTR-F4   AAATTTAATGTTTATTTACTTAA             
  ID2-5’UTR-R4 GGAAACTGAAAACTAAAACT                52             1.0-   
 
5  ID2-5’UTR-F5 GCCTTGTGTATGATGGTTTT     
  ID2-5’UTR-R5 ACCAACAGAACAAGGAGTGAT             58  1.0- 
 
6  ID2-5’UTR-F6 GAAGTGTCTGCTGGGAATGA                
  ID2-5’UTR-R6 TGGTGTAGAAAAGGGAGAGA              58  1.0- 
 
7  ID2-5’UTR-F7 GCAAGTGAGATAGCAAGGGA 
  ID2-5’UTR-R7 TAAAATAGGATGGGAAGGAA               56  1.0- 
 
8  1D2-Exon1F AGTAGAGGTGGCAGTGGTTG               
  1D2-Exon1R GATGCTTCCTTCTGGTTTTC                58  1.0- 
 
9  1D2-Exon2F TGATTATTTGTGGCTTCTGG 
  1D2-Exon2R GGTTCCCAGGTTTTACATTC                56  1.0- 
 
10 1D2-Exon3F CTACTGTGAAAAGCCCGAAG 
  1D2-Exon3R CCAGCAGCACAACTTCATCT               58  1.0- 
 
11 1D2-Exon4F GAGATAGGTCCAAATGAAGG 
  1D2-Exon4R ATGTAGATGTGACCCCTCCA               52  1.0- 
 
12 1D2-Exon5F AATCCACAAACTCAGACCAA 
  1D2-Exon5R CAAATGAGATAAGAGATAAGATGT      58  1.0- 
 
13 1D2-Exon6F TTTGGAACATAGAAGGCTGAG 
  1D2-Exon6R GCATAACCAACAGCGACAGT              52  1.0- 
 
14 1D2-Exon7F AAATCTGGAGGGCTTGGTCT 
  1D2-Exon7R TCAGAGCAGGCAGGATTCGC             58  1.0- 
 
15 1D2-3’UTR-F1 TTGTGAGACTGGCTTATGGC                
  1D2-3’UTR-R1 TGCTTTTTCTCTGTCTGCCT                58  1.0- 
 
16 1D2-3’UTR-F2 AGAACTCAGGGCAAAGACAG 
  1D2-3’UTR-R2 AGCACCTGAACACCACGA                  55  1.0- 
 
17 1D2-3’UTR-F3 GTCGTTCCCCTTGTTCAGAT 
  1D2-3’UTR-R3 TTTCCTTTAGTTTCCCATTG                55  1.0- 
 
18 1D2-3’UTR-F4 AATCTTTTTCTTTTGGCTCA 
  1D2-3’UTR-R4 TTTCAATACCCAATACCCAA               56  1.0- 
 
19 1D2-3’UTR-F5 CTCCTCTCCCTCTACCATTG 
  1D2-3’UTR-R5 GTTTGAGGTATGCTTTTTGGA            58  1.0- 
20 1D2-3’UTR-F6 CATCCAAAAAGCATACCTCAAAC 
  1D2-3’UTR-R6 AATGAAGCATACAGCTAGGC             58  1.0- 
21 1D2-3’UTR-F7 GCCTAGCTGTATGCTTCATT 
  1D2-3’UTR-R7 GATAATAAGTTGAGAGTGGTGAC      58  1.0- 
22 1D2-3’UTR-F8 GTCACCACTCT CAACTTATTATC 
  1D2-3’UTR-R8 TGATTTATCCAAGTATATACGTG        -   - 
23 1D2-IVS1F1 TGCCTCAGCCTCCCAAGTAG 
  1D2-IVS1R1 AAATGCTGGAGTCAGGGCCA             -   - 
24 1D2-IVS4F1 CCACGGAGGTAGGCAATC 
  1D2-IVS4R1 CAAAGCAAGAGCCAGAGC                 56  1.0- 
25 1D2-IVS6F1 CTGTCGCTGTTGGTTATGCC 
  1D2-IVS6R1 TTATCCATTCCCCTCTCATC               56  1.0- 
*PCR reaction without (-) 4% formamide 
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IV RESULTS 
1. RDBMS design and construction 
This section provides insight into design and implementation of RDBMS. SSADM method 
have been used in designing and analysis of the RDBMS for the current project. MS Access 
was used in implementing the RDBMS. Utilizing the LDM, the entities for the RDBMS had 
been identified and analysed. Having identified a possible entity, the validity of the entity 
should be confirmed by determining the attributes which constitute the entity. If it is not 
possible to allocate any such attributes, the validity of the entity may be in question. The 
entities and their possible attributes for the current application are shown in Table 5. 
 
Table 5 The identified entities and their possible attributes 
 Entity      Possible attributes 
• CLONE     Clone name, Clone length,   
Clone sequence, PCR band size, 
Clone source, Clone organism, 
Clone tissue 
 
• GENE     Gene ID, Gene name, 
Accession number, CDS,  
Gene length, Cytogenetic map, 
LocusLink ID, UGCluster, 
Number of exons, Aliases,  
Protein accession number  
 
• CLONE – GENE    Clone name, GeneID, Contig ID,  
Category ID, Subcategory ID, 
Library type, Search similarity, 
% of similarity, Genomic Contig, 
Similarity with respect to CDS,  
DNA source 
 
• EXON     ExonID, GeneID, Start of exon 
End of exon, Size of exon, 
Size of intron, Nucleotide sequence of 
the exon, Amino acid sequence of exon, 
Exon F-primer, Exon R-primer 
 
• CONTIG     ContigID, Contig length  
Consensus sequence of Contig 
• EXPRESSION    GeneID, Expression Assays, Probe,  
Transcript size (kb), Tissues panel, 
Tissue specificity 
• FUNCTION     GeneID, Accession  Number, Class  
function , Subclass function, Protein 
motif, Protein domain, Biology of the 
gene 
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A grid or matrix is constructed to aid the identification of relationships between the 
identified entities (Table 6). The grid is constructed by listing the entities along each 
of the two axis. The purpose of the grid is to ensure that each entity is considered in 
relation to every other entity so that relationships are not overlooked. To identify the 
relationships, each pair of entities must be checked for the possibilty of the existence 
of a relationship. When a relationship has been allocated, the degree of the 
relationship should be established. Most relationships will be one-to-many (1:M) or 
many-to-one (M:1). One-to-one (1:1) and many-to-many (N:M) relationships may 
appear at this stage of design, but they should be resolved later by the addition of link 
entities. If a one-to-one relationship is identified it should be examined closely to see 
if the two entities can be combined. Few cases where a 1:1 relationship can exist if the 
two entities have different keys, different lives and are governed by different time 
periods. Many-to-many relationships are not permitted in SSADM, they contradict the 
Master/Detail concept. In the current RDBMS the relationships between the entities 
were identified, and consequently an entity/entity matrix (or grid) was drawn up as 
shown in table 6. 
 
Table 6  Entity/Entity Matrix for the current RDBMS* 
Entity/Entity Gene Exon Clone Expression Function Contig 
Gene  M:1 M:1 1:1 M:1  
Exon 1:M      
Clone 1:M     1:M 
Expression 1:1      
Function 1:M      
Contig   M:1    
*1:M  means one-to-many relationship, whereas M:1 refers to many-to-one relationship 
 
A relationship must have a unique identifier with the following structure: 
<Subject entity name> <relationship link phrase> <object entity name>  
The relationship link phrase describes the entity from the perspective of the subject 
entity. A relationship line must be able to read from either end without any ambiguity. 
It is formulated as a plain English “Relationship Statement”, quoting optionality, 
meaning and degree. For example, the relationship statements for Figure 3, read: 
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A. Each GENE must be made up of one or more Clones. And each CLONE must 
be part of one and only one Gene. 
 
B. Each GENE must be made up of one or more Exons. And each EXON must be 
part of one and only one Gene. 
 
C. Each CONTIG must be made up of one or more Clones, and each CLONE 
must be part of one and only one Contig. 
 
When referring to relationships, it is convenient to have a way of referring to the 
entity at the ´one´ end and the entity at the ´many´ end. The entity at one end is 
referred to as the `Master` entity in the relationship, and the entity at the many end is 
the `Detail` entity. For example in the Figure 3A, the entity Gene is the master entity 
in the relationship, the entity Clone is the detail entity. 
Figure 3 O
follows: each
and only one
 
Having the 
is created 
regardless o
 
A major em
group them
This clone 
example, se
retinal pigmA.        CLONE 
        GENE 
ne-to-many relationship. 
 gene must be made up of
 gene. The same degree of
entities, attributes and r
which models the inf
f how this information is
phasis of RDBMS is to 
 into clusters that repre
duplication leads to da
quencing of 1002 ESTs 
ent (RPE1) (Figure 5B)
part of B.For example, the relation
 one or more clones and ea
 relationship can be applied
elationships being alloca
ormation requirements 
 going to be processed (
provide reliable identific
sent transcripts from the
ta redundancy that nee
yielded 46 clones that ha
. The  storage of RPE1 
        GENE 
part of
        EXON C.made up of 
        CONTIG made up made up  
ship in A can be read as 
ch clone must be part of one 
 to B and C. 
ted, a logical data model 
of the current system, 
Figure 4).  
ation of RPE ESTs and to 
 same gene (Figure 5A). 
ds to be normalized. For 
ve identity with B. taurus 
many times as well as its 
part of  
        CLONE 
                                                                                                                                      Results    
 
45
accession number and coding sequence (CDS) leads to data redundancy. Therefore, 
the data was split into two relations i.e. clone relation and gene relation. The 
aceession number is then used as a primary key to relate the two relations (Figure 5C). 
 
 
 
Figure 4 Logical Data Model showing the entities and their relationships created for 
the RPE-EST RDBMS. Each box represents an entity as summarized in Table 5. 
 
Using the RDA, the complete normalization table for the RDMBS was created as 
shown in Table 7. The process of converting Un-Normalised Form (UNF) relations 
into First Normal Form (FNF) relations involves the identification and removal of 
repeating groups of attributes from the UNF relation. A repeating group comprises 
one or more attributes for which multiple values may be present in a single instance of 
the UNF primary key. All repeating attributes must be removed from the UNF 
relation to a separate relation that has as its key, the key of the UNF relation, as well 
as additional attribute (or attributes) which will uniquely identify an occurrence of the 
repeating group. FNF relations are therefore relations which do not contain any 
repeating groups. For example, for some genes in our dataset there is a repeating 
group of data about clones. In addition, for each contig there is a repeating group of 
data about clones. In these cases, the original un-normalized relation is split into three 
relations in the FNF (Table7). 
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A. Clone redundancy and normalization 
 
3‘ UTR5‘ UTR
Clones
Gene
One transcript  
 
B. Data redundancy 
Plate ID Clone ID Gene Name AccessionNumber
Coding 
Sequence 
CDS
RPE01 A03F Bovine retinal pigment (RPE1) mRNA, 3' 
end Length = 1584
M81193 1..1477
RPE02 C11F Bovine retinal pigment (RPE1) mRNA, 3' 
end Length = 1584
M81193 1..1477
RPE02 F06F Bovine retinal pigment (RPE1) mRNA, 3' 
end Length = 1584
M81193 1..1477
RPE16 E12F Bovine retinal pigment (RPE1) mRNA, 3' 
end Length = 1584
M81193 1..1477
RPE22 B08F Bovine retinal pigment (RPE1) mRNA, 3' 
end Length = 1584
M81193 1..1477
 
 
 
C. Data normalization 
Plate 
ID
Clone
ID
Accession 
Number
RPE01 A03F
M81193
RPE02 C11F
M81193
RPE02 F06F
M81193
RPE16 E12F M81193
RPE22 B08F M81193
Accession 
Number Gene Name
Coding 
Sequence 
CDs
M81193
Bovine retinal pigment (RPE1) 
mRNA, 3' end Length = 1584
1..1477
 
primary
key  
Figure 5 Clones/data redundancy and normalization. (A) In our RPE cDNA library some 
genes are  represented by more than one clone (1:M), this clone redundancy was normalized 
by considering those clones from the same gene (identical or nonoverlapping) as 
corresponding to one transcript; (B)  Gene name, like RPE1, is  repeated many times as well 
as accession  number and coding sequence (CDS); (C)  Data split into two relations; clone 
relation and gene relation. The clone relation comprises of Plate ID, clone ID and accession 
number, whereas the gene relation contains the gene name, accession number, and CDS. 
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To transform FNF relations into Second Normal Form (SNF) relations, each FNF 
relation with a compound key must be examined. Each attribute which forms part of 
the key of an FNF relation must be considered to determine whether the key would 
still uniquely identify all occurrences of the relation if the attribute in question were to 
be excluded. If such an attribute is identified, it should be removed from the primary 
key of the relation, but retained as a non-key attribute. For example, data about exons 
are determined by Exon ID and Gene ID alone i.e. given the value of Gene ID and 
Exon ID the other values about exons can be determined (Table 7). 
 
The step of converting SNF relations into Third Normal Form (TNF) relations 
involves the identification and documentation of inter-data dependencies. Each pair of 
non-key attributes in SNF relation needs to be examined to identify whether there is 
any dependency between the two attributes. If inter-data dependency is identified, the 
dependent attribute is removed to a separate TNF relation as a non-key attribute. The 
primary key of this new TNF relation is the attribute on which the removed attribute 
is dependent. The primary key of the new TNF relation becomes a foreign key in the 
SNF relation from which the TNF relations has been created. For example, the 
expression and functional data about the gene has nothing to do with the other gene 
informations like CDS and number of exons. So, both expression and function are 
separated into a new relation (Table 7), but are related to the gene relation by a 
foreign key which in this case is the GeneID. 
 
In order to validate the LDM with the results of RDA, the TNF relations must be 
converted into a data structure which can be compared with the LDM. An entity box 
is drawn for each TNF relation. Each entity box must be named and in each box, the 
relation’s primary and any foreign keys are shown. 
 
Figure 6 shows the tables that were designed and implemented for the current RPE-
ESTs RDBMS. These included tables corresponding for each entity identified for the 
system as shown in Table 5. Seven tables for entities GENE, CLONE, CONTIG, 
EXON, EXPRESSION, FUNCTION, and GENE-CLONE were designed and 
developed.  
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Table 7 Complete normalization table for the current RDBMS 
UNF (Un-normalised Form)    FNF (First Normal Form)  
 
Clone name      Gene ID 
Gene name      Gene name 
LocusLink ID      LocusLink ID 
Protein accession number     Protein accession number  
Aliases       Aliases 
Clone organism      Accession number 
Clone tissue      Coding sequence CDS 
Clone source      Number of Exons 
Library type      Exon ID 
PCR band Size (bp)      Start of Exon 
Clone Sequence      End of Exon 
Clong length      Length of Exon 
Gene ID       Exon Size (bp) 
Accession number      Nucleotide sequence of Exon   
Coding sequence CDS     Amino Acid  sequence of Exon 
Number of Exons      Exon F-primer 
Exon ID       Exon R-primer 
Start of Exon      Expression assays 
End of Exon      Transcript size (kb) 
Length of Exon      Probe   
Exon Size (bp)      Tissues panel 
Nucleotide sequence of Exon     Tissue specificity 
Amino Acid  sequence of Exon     Class function 
Exon F-primer      Subclass function 
Exon R-primer      Protein motif 
% of homology      Protein domain 
Place of homology – Query     Biology of the gene 
Place of homology – Subject      
Similarity DNA Source     Contig #       
Category ID      *Category ID    
Similarity with respect to CDS     Contig consensus sequence 
Comments/Remarks      Contig length 
Expression assays          
Transcript size (kb)      Clone name  
Probe       Gene ID     
Tissues panel      *Contig # 
Tissue specificity      *Category ID    
Class function      % of homology    
Subclass function      Clone organism 
Protein motif      Clone tissue   
Protein domain      Clone source 
Biology of the gene      Library type    
Genomic Contig      Clone sequence 
Human Genomic Similarity     Clone length 
Contig_Percentage of homology      PCR band Size (bp) 
Contig_Place of Homology – Query    Place of homology – Query 
Contig_Place of Homology – Subject    Place of homology – Subject 
Contig_commnets/Remarks     Similarity DNA Source 
Subcategory      Similarity with respect to CDS 
Chromosome ID      Genomic Contig 
Cytogenetic map      Human Genomic Similarity 
Contig #       Contig_Percentage of homology 
Contig consensus sequence     Contig_Place of Homology – Query 
Contig length      Contig_Place of Homology – Subject 
       Contig_commnets/Remarks 
       Subcategory 
       Chromosome ID 
       Cytogenetic map 
       Comments/Remarks 
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Table 7 (continued) 
SNF (Second Normal Form)    TNF (Third Normal Form)  
 
Gene ID       Gene ID
Accession number      Accession number 
Gene name      Gene name 
LocusLink ID      LocusLink ID 
Protein accession number     Protein accession number 
Aliases       Aliases  
Coding sequence CDS     Coding sequence CDS 
Number of Exons      Number of Exons 
Expression assays 
Transcript size (kb)      Gene ID     
Probe       Expression assays 
Tissues panel      Transcript size (kb) 
Tissue specificity      Probe 
Class function      Tissues panel 
Subclass function      Tissue specificity   
Protein motif        
Protein domain       Gene ID
Biology of the gene      Class function 
       Subclass function 
Exon ID       Protein motif 
Gene ID       Protein domain 
Start of Exon      Biology of the gene 
End of Exon 
Length of Exo Exon IDn      
Exon Size (bp)      Gene ID 
Nucleotide sequence of Exon     Start of Exon  
Amino Acid  sequence of Exon     End of Exon 
Exon F-primer      Length of Exon 
Exon R-primer      Exon Size (bp) 
       Nucleotide sequence of Exon 
       Amino Acid  sequence of Exon  
Clone name      Exon F-primer 
Clone organism      Exon R-primer 
Clone tissue       
Clone source      Clone name
Library type      Clone organism 
Clone sequence      Clone tissue    
Clone length      Clone source 
PCR band Size (bp)      Library type 
       Clone sequence 
Contig #         Clone length 
*Category ID      PCR band Size (bp) 
Contig consensus sequence   
Contig length      Contig #   
  *Category ID         
Clone name      Contig consensus sequence 
Gene ID       Contig length 
*Contig #         
*Category ID      Clone name
% of homology      Gene ID
Place of homology – Query     *Contig #   
Place of homology – Subject     *Category ID 
Similarity DNA Source     % of homology 
Similarity with respect to CDS     Place of homology – Query 
Genomic Contig      Place of homology – Subject 
Human Genomic Similarity     Similarity DNA Source 
Contig_Percentage of homology     Similarity with respect to CDS 
Contig_Place of Homology – Query    Genomic Contig 
Contig_Place of Homology – Subject    Human Genomic Similarity 
Contig_commnets/Remarks     Contig_Percentage of homology 
Subcategory      Contig_Place of Homology – Query 
Chromosome ID      Contig_Place of Homology – Subject 
Cytogenetic map      Contig_commnets/Remarks 
Comments/Remarks      Subcategory 
       Chromosome ID 
       Cytogenetic map 
       Comments/Remarks 
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Figure 6 The tables that were designed and constructed for the RDBMS. Each table 
represents an entity as summarized in Table 5.  
 
An important task after creating tables, is to decide on the appropriate field type 
values, default values, captions, whether the field needs to be unique, whether the 
field needs to be indexed, any input masks and visual formatting. Figure 7 shows the 
fields created for the GENE table associated with the current application. A final 
important area involved with table creation is indexes. An index is used in a table 
much like index of a book. A type of index that every table should have is a primary 
key. Primary keys ensure uniqueness within a table and are vital for creating one-to-
many relationships. Figure 8 shows the process of creating an index for Gene ID field 
in GENE table. In this case, Gene ID serves as the primary key for this table. 
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Figure 7 The GENE table (tblGene) showing the fields created for the RDBMS. For 
example Gene Name, Gene ID, accession number. Each field represents an attribute 
for entity as summarized in Table 5 and in the third normal form (TNF) Table 7. 
 
 
 
Figure 8 Primary key (index) created for the Gene table (tblGene). In this instance, 
Gene ID serves as the primary key for this table. 
 
The RDBMS was designed and implemented into eight main tab sections or elements 
for easy access to information about clones, identified genes and their related 
information. Those eight tab components comprise the main menu of the system, as 
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can be seen in Figure 9. The main menu includes: main, clone informaion, 
similarity/identity information, expression, function, known genes, search and others. 
The main tab component is containing Internet links to other valuable bioinformatic 
tools necessary for sequence analysis and annotations (Figure 9). Navigation buttons 
are always at the bottom, and users can exit from the system at any time. 
 
 
Figure 9 The Main menu of the RDBMS showing the various tabs representing 
forms that users can interact with to access the relevant information about clones, 
genes, expression, and functional profiling.  
 
Figure 10 shows the fields necessary to capture most of the information needed about 
the clone in question. As described in Table 2, we need to keep information about 
RPE clones derived from the subtracted cDNA library, for example, clone name, 
clone length, clone sequence, clone tissue and clone organism. The first number in the 
Clone name refers to the RPE plate number, the letter and number that follows 
represent the plate co-ordinates. Using the clone sequence, Blast searches can be 
initiated and the result of the identity/similarity of the clone is entered into the 
similarity information page, just next to the clone page (Figure 11). Additionally, we 
need to keep track of the clone identity/similarity with reference to known, predicted 
gene ID, gene name, accession number, genomic contig, coding regions (CDS), Locus 
link ID and cytogentic map. We are also interested in clones that show no homology.  
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Figure 10 The Clone page showing the fields necessary to capture most of the 
information needed about the clone in question. The first number in the Clone name 
refers to the RPE plate number, the letter and number that follow representing the 
plate co-ordinates. 
 
 
 
Figure 11 The Similarity tab page showing the clone 01-F9F with similarity to 
BCDO1 gene on chromosome 16 band q21-q23 with GenBank acc. No. NM_017429. 
 
In this case, the laboratory-intern gene symbol can easily be entered in the Gene ID 
field, and the “no homology” status can be described in the subcategory field, either 
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as “unknown with or without exon-intron boundaries” or “no significant similarity 
was found” (Figure 12). 
 
 
 
Figure 12 The Similarity tab page showing the clone 10-D9R that showed no 
significant similarity as denoted in subcatergy field. The unknown status of this clone 
is shown as the laboratory-intern gene symbol “uk148” in Gene ID field and 
“unknown” in the accession number field. 
 
Another area of interest which requires the storage of information is the expression 
profiling of either the clones or identified genes. Genes expressed in a certain tissue 
can be assumed to be important for the function of this tissue. The expression data can 
have two sources; either from the published literature mainly for known and predicted 
genes or from experiments using Northern blot or RT-PCR for unknown transcripts or 
for known genes that have no expression data in the published literature. Figure 13 
shows the clone RPE06-C10 that was found using Northern blot analysis on bovine 
RNA samples to be expressed in retina and RPE with abundant expression in RPE. 
No expression was detected in other tissues examined. Analysis of the complete 
sequences of SSRPE cDNA library has identified a number of many known and 
predicted genes. With complete coding sequences, protein sequences can be examined 
for motifs, domains, and biochemical characteristics that may suggest function. The 
most challenging problem will then be to determine the functions of these genes. 
Figure 14 shows the form that was designed and implemented to capture, and to 
display, the most important information needed about the function of the known and 
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predicted genes. A variety of tools, including BLASTN, BLASTX, LocusLink, 
SwissProt, Source, Pfam and published literature were used for the functional 
annotation of the known and predicted genes. For example, in Figure 14 the Function 
tab page shows the class function and subclass function of the BCDO1 gene as 
vitamin A metabolism/transport and vitamin A metabolism respectively. 
 
 
 
Figure 13 The Expression page showing the clone RPE06-C10 that was found, using 
Northern blot hybridization on bovine RNA, to be expressed in retina and RPE with 
abundant expression in RPE. No expression was detected in other tissues examined. 
 
Efforts were made to normalize the  redundancy of the known genes and to group 
them into clusters that represent transcripts from the same gene (Figure 5A). Figure 
15 shows the information restricted to known genes only and its related information 
such as expression and function as well as a search option to find the desired gene. 
Figure 16 shows other information such as clone ID, clone source, clone microtitre 
plate, blast date, and revision date. These are for monitoring and organisation 
purposes only. For example, it is extremly important to know the first date of blasting 
the clone in question as well as the last revision date before any further decision is 
taken. In addition, clone source is for statistic purposes to know if the clone was 
sequenced in-house or at Lynkeus Biotech. 
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Figure 14 The Function tab page showing the class function and subclass function 
of the BCDO1 gene. 
 
 
 
 
 
Figure 15 The Known genes tab page showing the information restricted to known 
genes only as well as a search option to find a certain gene and its related information 
such as expression and function. 
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Figure 16 The others tab page showing other information such as clone ID, clone 
source, clone microtitre plate, blast date, and revise date. These are for monitoring 
and organisation purposes only. 
 
The Search form Query by Form (QBF) interface contains text boxes or combo 
boxes for each of the criteria that the user of the RDBMS can specify (Figure 17). The 
user clicks the check box to indicate that a particular criterion to be used. The process 
of clicking this check box enables the text boxes or combo boxes in which the values 
for the criterion are then entered. The screenshot on Figure 17 illustrates how the 
search form could be used to ask the question: Show me all the RPE known genes 
that function in metabolic pathways? Figure 18 shows the results of such a search. 
 
When the user activates the Find Matches button, the results form (Figure 17) is 
displayed containing the records that match the criteria specified by the user (Figure 
18). When the Print button is pressed, the report containing those records is 
previewed on screen (Figure 19).  
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Figure 17 Search form showing Query by Form (QBF) interface illustrates how the 
search form could be used to ask the question: Show me all the RPE known genes 
that function in metabolic pathways? Then, as the Find Matches is activated, the 
result form should display the records that match the criteria specified by the user 
(Figure 18). 
 
 
 
Figure 18 Results form showing RPE known genes that function in metabolic 
pathways, as well as their in silico expression profiling, cytogenetic map locations, 
LocusLink IDs, and accession numbers. 
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Figure 19 Report form showing an example of RPE known genes  
 
 
2. Analysis of the SSRPE cDNA library 
In the present study, 2379 expressed sequence tags (ESTs) from SSRPE cDNA library 
of bovine were analyzed. The length of inserts was in the range of 0.2 to 2 kb. The 
average readable sequence length, on which the following analysis was based, was 
approximately 300-600-bp. To overcome the problem of EST redundancy and to 
increase the length of the sequences, facilitating annotation by homology searches, a 
clustering process was performed. In this clustering process, RPE EST sequences that 
have a sufficient region of similarity are joined into a cluster. Thus, sequences 
possessing overlapping regions and representing a single gene are joined into the 
same cluster, therefore decreasing redundancy. 
 
2.1 Phase I: Analysis of 1002 ESTs 
In a first phase, 1002 SSRPE cDNA clones were sequenced and blasted to available 
sequences in the non-redundant GenBank/EMBL and dbEST databases (January – 
May 2001). Our analysis revealed that a total of 590 ESTs (59%) represent known or 
predicted genes, while 395 ESTs (39%) did not match to known transcripts. Of these 
245 ESTs matched to ESTs and genomic sequences, and 150 ESTs showed no 
homology to sequences available in the nucleotide databases (Table 8).  
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Correction for redundancy in the category of ESTs representing known genes was 
done by cluster analysis and sequence alignments to known transcripts, and showed 
that on average a single gene was represented by almost 5 ESTs (factor 4.8) (Table 8). 
On the other hand, the redundancy in the remaining categories was lower as many of 
the non-overlapping ESTs corresponding to only partially known genes could not be 
linked together. As a result of redundancy correction, 379 normalized transcripts were 
obtained (Table 8). 
 
Table 8 Summary of 1002 ESTs derived from RPE cDNA library (as of May 2001) 
                                                                                                          Unique 
                                                                      Clones           transcripts 
                                                                      ------------        ------------- 
            Category                                            n         %         n           % 
 
I Known genes    580 57.9  120 31.7 
II predicted genes   10 1.0  7 1.8 
III ESTs/genomic sequences  245 24.5  163 43.0 
IV No homology    150 15.0  86 22.7 
V Mitochondrial transcripts  17 1.6  3 0.8 
 Total     1002   379 
 
The representative clone sequences of the 376 in silico normalized transcripts (minus 
the 3 mitochondrial transcripts) were blasted against the human genome draft 
sequence (http://www.ncbi.nlm.nih.gov/genome/seq/page.cgi?F=HsBlast.html&& 
ORG=Hs). Many of the singleton ESTs not previously linked to a specific mRNA 
transcript could be located within the immediate 3’ UTR (untranslated region) of 
known or predicted human genes. A second round of normalization (as of October 
2001) resulted in the identification of 168 known, 51 predicted, and 1 unknown 
transcript with exon-intron boundaries. In addition, 14 transcripts without exon-intron 
boundaries, and 41 ESTs showed no significant similarity (Figure 20). 
 
In summary, a total of 1002 bovine RPE-ESTs represent 168 known human genes and 
approximately 107 predicted or as yet unknown genes. To evaluate the SSRPE cDNA 
library for the degree of enrichment for RPE-specific transcripts we collected in silico 
data on expression profiling of the 168 known genes from published sources. Overall, 
data were obtained for 153 genes. Approximately 17% (26/153) of these genes were 
RPE and/or retina-specific and approximately 5% (7/153) were specifically expressed 
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in retina and brain. Extrapolating these data leads us to predict that the approximately 
107 unknown genes identified in the first phase of this study could include 15-20 
novel RPE/Retina-specific genes. 
 
A
61%
B
19%
C
5%
D
15%
  
Figure 20 Results of blast searches of 376 normalized transcripts (as of October 2001) 
376 normalized cDNA clones (minus the 3 mitochondrial transcripts) were compared to the 
human genome draft sequence. The clones that showed homology are indicated as 
percentages and are shown at the bottom of the diagram. A. Identities to known human genes. 
B. Identities to human predicted genes. C. Similarity to unknown transcripts D. No significant 
similarity to human sequences. 
 
2.2 Phase II: Analysis of additional 1377 ESTs 
In a second phase, additional 1377 SSRPE cDNA clones were sequenced and blasted 
against a recent release of the human genome draft sequence. This raised the total 
number of the bovine RPE cDNA clones to 2379. Contig assembly program  CAP3 
(Huang and Madan, 1999) was used to assemble the high quality sequences into 
clusters or singletons. 1.2% of the 2379 RPE-ESTs contains vector sequences and was 
excluded from further analysis. 5% of the RPE-ESTs showed homology to multipe 
chromosomes and were not included in the further assembly process. The rest of the 
ESTs (2245) were assembled into 175 contigs and 509 singletons, which revealed 684 
unique genes in the data set. The frequency of EST distribution after CAP3 analysis 
and BLAST searches (as of March 2003) is shown in Table 9. Most clusters 
constained 1-3 ESTs and the largest cluster contained 151 ESTs. 
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Table 9 Summary of the abundance occurring in the 2379 RPE-ESTs*(as of March 2003) 
Frequency of Known  Uknown  Gene Names Accession Number 
EST hits 
151 1 - VMD2 NM_004183 
87 1 - TTR NM_000371 
79 1 - TRPM3 XM_036123 
78 1 - TNRC15 XM_209467 
68 1 - CDH3 NM_001793 
63 1 - RLBP1 XM_007697 
52 1 - RPE65 NM_000329 
44 1 - GSTM NM_000561, NM_000850 
39 - 1 - - 
37 2 - RHO, RGR NM_000539, NM_002921 
36 1 - SERPINF1 NM_002615 
35 3 - RDH10 NM_172037 
   DKFZP564K1964 NM_015544 
   SLC2A1 NM_006516  
33 1 - LRAT NM_004744 
32 1 - LOC283211 XM_210938 
28 - 1 - - 
27 1 - CA14 NM_012113 
26 - 1 - - 
22 1 - SLC4A5 NM_021196 
19 1 - CST3 NM_001322 
18                                 3 - RCV1, MAOB NM_002903, NM_000898  
                                                                         FMOD  NM_002023 
17 1 - ATP1B2 NM_001678 
15 2 - DKFZP761G0122 NM_152661 
   SKIP NM_016532 
14 - 1 - - 
13 2 - BCDO1, TRPM1 NM_017429, NM_002420 
12 1 - GPM6B NM_005278 
11 2 - ABHD6 NM_020676 
   LOC119587 XM_058409 
10 1 - RDS NM_000322 
9 1 - KIAA1576 NM_020927 
8 5 2   
7 5 -   
6 5 2   
5 16 -   
4 9 2   
3 30 5   
2 47 11   
1 192 317 
   
Total         341         343   
*The 2379 RPE ESTs  were sequenced in two phases. In phase I, 1002 ESTs were sequenced 
in-house, whereas in phase II, 1377 were sequenced at Lynkus Company (Würzburg). 
 
The analysis of 2245 ESTs revealed that some of the RPE genes were represented in 
the library by more than one EST. The top most abundant ESTs are shown in Table 9. 
From the 684 unique transcripts identified in this study, 341 (49.2%) were attributed 
to known genes (Table 9) according to NCBI database using the BLAST program 
(Altschul et al., 1990) and the human genome draft sequence 
(http://www.ncbi.nlm.nih.gov/genome/ seq/page.cgi?F= HsBlast .html&&ORG=Hs). 
Consequently, no hits were found for 343 (50.2%) (Table 9). Many of these, if not all, 
should represent novel RPE genes, but further investigations will be required. 
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3. Functional profiling of the reported known RPE genes 
A variety of tools, including BLASTN, BLASTX, LocusLink, SwissProt, Source, 
Pfam and data from published literature were used for the functional annotation of the 
known and predicted genes. The identified 341 known and predicted genes were 
found to represent 18 different functional groups (Figure 21). A comprehensive list of 
these functional groups including a list of all genes can be found in the Appendix 
(VIII, 1). Of the 341 known genes, no function could be assigned to 24.4%. Genes 
involved in metabolic pathways are represented and corresponded to 14.5% of the 
total number of annotated genes. 12.5% of the known genes are involved in various 
types of transport. We also found that 10.2% of the known genes are involved in cell-
cell signalling.  5.8% of the known genes fall into the cell defence group as RPE is 
subjected to high oxidative stress.  2.6% of the identified known genes in this study 
are involved in vitmain A metabolism and transport, including RPE65, RLBP1, 
RBP1, LRAT, BCDO1, RBP4, and RDH5. 3.8% of the reported genes are involved in 
transcriptional factors, including OTX2 (orthodenticle homolog 2 (Drosophila), NRL 
(neural retina leucine zipper). 2% of the reported genes are involves in 
phototransduction and 1% are lysosomal enzymes. 
 
4. Comparison to similar studies  
Wistow et al. generated 10,000 ESTs from the human RPE/choroid for the NEIBank 
project (Wistow et al., 2002a). Comprehensive analysis of the NEIBank RPE unique 
gene clusters revealed that 3820 attributed to known genes in the public databases and 
the rest of 2480 have no matches (as of March 2003). Comprehensive comparison of 
the NEIBank 3820 unique RPE clusters with our datasets of 341 RPE known genes 
shows that only 146 are overlapping between the two libraries (Figure 23 and Table 
10). 42.82% of our identified RPE genes are overlapping with only 3.82% of 
NEIBank RPE known genes. 10 of the 146 overlapping genes are involved in retinal 
dystrophy diseases (shown as bold and underlined in Table 10). 
Crosstab query was designed and implemented to compare the 3820 NEIBank 
RPE/choroid and our 341 SSH-RPE known genes (Figure 22). The comparison shows 
that only 146 are overlapping between the two libraries (Figure 23 and Table 10). 
This illustrates the potential of MS access in importing external tables and compares 
them with the existing tables in the database using the crosstab query feature. 
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Figure 21 Functional groups of RPE known genes identified in this study. A total of 
341 non-redundant genes were classified into 18 groups according to their probable 
function. 
 
 
 
Figure 22 Crosstab query used to compare the 3820 NEIBank RPE/choroid and the 
341 our SSRPE known genes. The comprehensive comparison shows that only 146 
are overlapping between the two libraries (Figure 23 and Table 10). 
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Table 10 The 146 overlapping RPE genes between NEIBank and SSH-RPE library, 
showing the gene symbols 
 
ABCA4 DDOST GPM6A MYRIP SAG SUOX 
ABR DKFZp564D206 GPRC5B NDUFA4 SAT TEGT 
ACAA2 DKFZP564K1964 GPX4 NICE-3 SCMH1 TGFBI 
AEBP1 EBP H2BFQ NIFIE14 SDF2 TIMP3
AHCYL1 EFEMP1 HERPUD1 NPR2 SDHA TNRC15 
ARL6IP ENPP2 HNRPDL NUCB1 SERPINA5 TTR 
ATP1A3  ERH HSPC111 OLFM1 SERPINF1 TRIM41 
ATP1B2 EZH1 HSPCB OTX2 SFRP2 TSC22 
ATP5B FADS1 IPO13 PDK2 SGK TSPAN- 
ATP5G2 FLJ10803 JWA PGCP ShrmL TUBG1 
ATP5L FLJ11305 KIAA0157 PGRMC1 SIAH2 TYRP1 
ATP6V0A1 FLJ12287 KIAA0446 PITPN SLC13A3 UBE1 
B4GALT1 FLJ32069 KIAA1576 PPM1B SLC16A1 VEGF 
BHLHB2 FLOT2 LASS2 PRDX1 SLC22A8 VMD2
BMP7 FMOD LDHB PRKWNK4 SLC2A1 WBP1 
BSG FOXO1A LOC151361 PRSS11 SLC4A5 XT3    
BZW2 FRZB LOXL1 RAB5B SLC6A13  
CA12 FTH1 MAGED1 RAB7 SLC9A3R1  
CLIC6 GALNT10 MAP2K1 RDS SMPD1  
CLIPR-59 GAPD MAPKBP1 REQ SNX5  
CLU GLUL MFRP RGR SPOCK  
COG1 GNAT1 MGC23937 RHO SPTAN1  
COG7 GNB3 MGC32043 RLBP1 SRRM2  
COX4I1 GOT1 MLF2 RPE65 SSBP2  
CST3 GOT2 MYL6 RPS3 STUB1  
CTSK    GPI                MYO5A  RYK  STXBP1 
 
 
  
 
Figure 23 Breakdown of the ESTs sequences of NEIBank RPE/choroid and SSH-
RPE library showing the 146 overlapping RPE genes between the two libraries. 
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5. Cloning and characterization of RPE01-D2 and RPE6-C10  
5.1 RPE01-D2 
Clone RPE01-D2 was derived from the SSRPE cDNA library and found to show 
similarity to exon 4 and exon 5 of the human LOC145226 (later FLJ30273, now 
RDH12, accession number NM_152443) as shown in Figure 25. To establish the 
expression profile of RPE01-D2, Northern blot analysis was performed in bovine 
tissues using a 400-bp RPE1-D2 probe. A 2.1-kb was detected in bovine retina and 
RPE with abundant expression in retina, but not in bovine heart, liver, brain, kidney 
and lung (Figure 24). The retina specific expression of LOC145255 was further 
confirmed by RT-PCR analysis in adult human tissues (Figure 26). To isolate the full-
length cDNA sequence, RT-PCR was performed. First-strand cDNA from human 
retina was used as a template using the primer pair RPE1-D2F/ RPE1-D2R (Figure 
25). RT-PCR revealed three products, the larger is 950-bp in size. The RT-PCR 
products were ligated into pGEM® T-easy vector (Promega) and then transformed 
into E. Coli. Using blue/white colour selection. Positive clones were selected, and 
were sequenced as described. The sequencing revealed a 1112-bp transcript with an 
ORF of 951-bp. The presence of an in-frame stop codon 66-bp upstream of the 
putative start codon strongly suggests that the entire coding region has been isolated. 
The protein predicted from the ORF consists of 316 amino acid residues with a 
calculated molecular mass of 35.1 kDa. The exon/intron boundaries of human RDH12 
were determined by sequence alignment of cDNA clones to the genomic sequence. 
RDH12 spans approximately 13.6 kb and consists of 7 exons and 6 introns (Table 11). 
The exons range in size from 68 to 210 bp. Intron sizes range from approximately 500 
bp to 4.3 kb. All the 5`-donor and 3`-acceptor sites are consistent with the GT-AG 
consensus for pre-mRNA splicing recognition sequences. The gene maps to 
chromosome 14q23.3. 
  
Table 11 Exon/intron Boundaries of the human RDH12 gene 
Exon Exon size (bp)  Intron size (kB)   5` donor  3` acceptor 
1 68   1762  CATCAGgtttgtct cgatagGAAGT 
2 119   507  GCCGAGgtaagt  acccagGAGCCC 
3 156   796  TGGCAGgtgagg  ctatagAGGAAA 
4 105   825  ACCTGGgtaagt  tcacagGCCACT 
5 210   2000  TCCAAGgtaagt  tcccagGCACCG 
6 190   4365  CTTCAGgtgtgt  ctccagTGACTG 
7 103 
Note. The exon sequences are shown in uppercase letters, and the intron sequences are displayed in 
lowercase letters. The gt-ag consensus sequences in the splicing sites are shown in boldface type. 
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Figure 24 Northern blot hybridization of RPE01-D2 probe (400-bp) to bovine RNA 
samples. A signal about 2.1-kb was strongly detected in retina, weakly in RPE, but 
not in other tissues. G3PDH expression served as a control for cDNA integrity 
(Provided by Rahman). 
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Figure 26 RT-PCR analysis of LOC145255 (RDH12) in human tissues with primer 
pair RPE1-D2F/R. The β-glucuronidase gene (GUSB) served as a positive control. 
 
5.2 RPE06-C10 
5.2.1 Genomic structure and expression pattern 
32 clones from our SSRPE cDNA library were assembled into a 844-bp contig (ID 
09), only 5 clones are shown in Figure 27. RPE06-C10 is one of those 32 clones, and 
therefore was used as a representative clone for this contig in expression experiments. 
The consensus sequence of this contig or cluster was found to show similarity to the 
3` UTR of an intronless gene that is not annotated in the Human Genome Sequence 
draft (Figure 27). I will be referring to this single-exon gene as 6-C10. Northern blot 
hybridization using RPE06-C10 clone as a probe and bovine RNA samples revealed 
that it is expressed highly in RPE and weakly in retina, but not in other tissues 
examined (Figure 28). The specificity of retina and RPE expression of 6-C10 was 
further confirmed by RT-PCR analysis in adult human tissues using primer pair 
RPE06-C10F3/RPE06-C10R3 (Figure 29). In addition, this gene was also found to be 
expressed in human lung. 
 
This single exon gene is highly GC-rich (77%) and represents a highly conserved 
sequence between human, mouse and rat (Figure 27). GC rich sequences can be 
extremely difficult to RT-PCR amplify and to sequence. RPE06-C10 was amplified 
using 2X PCRx Enhancer solution using 3 pair of primers that were designed in an 
overlapping manner to cover the entire length of the single exon gene (Figure 27). 
Recently a newly identified Locus (LOC283211) that is located tail to tail with 6-C10 
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was included in the NCBI database (Figure 27). LOC283211 encodes also a single 
exon gene. 
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The genomic organization of 6-C10 was investigated by performing PCR 
amplification on genomic DNA template, using the 3 sets of oligonucleotide pairs 
encompassing the 5` and 3` ends of the 6-C10 mRNA transcript. The size of the 
resulting PCR products coincided with that of the 6-C10 cDNA used as template, 
demonstrating that cDNA corresponds fully to the genomic DNA suggesting that 6-
C10 is an intronless gene. The gene maps to chromosome 11q13.3. 
 
5.2.2 Analysis of the predicted cDNA sequence 
A single long open reading frame of 1149 bases was identified, encoding a putative 
protein of 382 amino acids. The transcription start site was estimated to be 1953-bp 
upstream of the ATG start codon. The predicted molecular mass of 6-C10 is 40.4 
kDa. Amino acid sequence comparisons to known proteins in the database indicate 
significant homology to the leucine rich repeat (LRR) domain. Proteins belonging to 
the LRR superfamily are thought to be involved in specific protein-protein and 
protein-matrix interactions (Buchanana and Gay, 1996). 
 
 
2.3 - 2.5 kb
G3PDH
 
 
Figure 28 Northern blot hybridization of RPE06-C10 probe (600-bp) to bovine RNA 
samples. A signal about 2.3-2.5 kb was strongly detected in RPE, weakly in retina, 
but not in other tissues. G3PDH expression served as a control for cDNA integrity 
(Provided by Rahman). 
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  650 bp
 GUSB 
 
Figure 29 RT-PCR expression analysis of RPE06-C10 single-exon gene in human 
tissues with primer pair RPE06-C10F3/R3. The β-glucuronidase gene (GUSB) served 
as a positive control. 
 
 
6. SNP genotyping for RDH12 
To facilitate future association studies for the RDH12, SNP mapping was conducted 
using a combination of DHPLC and direct sequencing. A total of  25 fragments 
derived from the RDH12 locus were PCR amplified and run on DHPLC or were 
directly sequenced. 12 SNPs were identified (Table 12). 5 SNPs showed allele 
frequency higher than 20% (frequency shown in bold and underlined in Table 12). 7 
out of these 12 SNPs showed allele frequnecies less than 20% for the minor allele. 4 
of the 7 lower allele frequency SNPs are in strong linkage disequilibium (shown with 
blue background in Table 12).  
 
SNPs identified for the RDH12 gene through the dbSNP were downloaded from 
GeneCards (http://bioinfo.weizmann.ac.il/cards-bin/carddisp?RDH12&search=DH12 
&suff=txt) and were compared to those identified. Table 13 summarizes the 
comparison between the dbSNPs and those identified in the present study. 8 out of the 
10 dbSNPs were covered in the current investigation. Only 3 of those 8 were detected 
and only 2 of these 3 are of high frequency (>20%). The identified SNP IVS6+539 
corresponds to dbSNP (rs718212) by frequency (Table 13).  
 
The identification of SNPs in the RDH12 region was achieved by direct sequencing 
and dHPLC scanning. The main focus of SNP identification was within the coding 
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region and exon/intron boundaries of the candidate gene, as well as 5 kb upstream and 
downstream of the 5’ and 3’ UTR, respectively. To increase the power to detect 
SNPs, we rescreened the RDH12 gene in 48 individuals by direct sequencing. The 
region analyzed was a rescreening of the 23,400 bp encompassing 5 kb upstream of 
the coding region, thus it may contain regulatory elements of this gene. In addition, all 
the exons of RDH12 were screened. 12 new SNPS were identified from direct 
sequencing of the 23.4-kb region. 
 
Table 12 SNP card for RDH12 gene 
location PCR fragment SNP ID* nucleotide 
Amino 
Acids frequency fequency 
      change  change  (allels) f 
5'UTR 1D2-5'UTR-F2/R2 -3924 -3924T>C   10/96 0.10 
5'UTR 1D2-5'UTR-F5/R5 -3651 -3651T>C   10/96 0.10 
5'UTR 1D2-5'UTR-F7/R7 -874 -874insAT   24/96 0.25
intron 2 1D2-ex2F/R IVS2+54 IVS2+54G>A   7/96 0.07 
intron 2 1D2-ex2F/R IVS2+60 IVS2+60A>G   26/96 0.27
intron 2 1D2-ex2F/R IVS2+151 IVS2+151G>A   1/96 0.02 
intron 2 1D2-ex2F/R IVS2+179 IVS2+179G>A   2/96 0.02 
exon 5 1D2-ex5F/R 482 482G>A Arg482Gln 10/96 0.10 
intron 6 1D2-IVS6F1/R1 IVS6+539 IVS6+539T>C   28/96 0.29
intron 6 1D2-ex7F/R IVS6-260 IVS6-260C>G   21/96 0.22
3'UTR 1D2-3'UTR-F2/R2 2029 +2029G>A   10/96 0.10 
3'UTR 1D2-3'UTR-F7/R7 4819 4819C>T   31/96 0.32
*SNP ID is corresponding to the location of the identified SNP in the genomic sequence of 
RDH12 gene. For example, the SNP –3924 is located about 3924 bp upstream of the start 
codon of the gene, whereas the SNP 4819 is located 3868 bp downstream of the stop codon. 
The number 4819 is derived from adding the 3868 to 951 that represents the coding regions 
(cDNA) of the RDH12. 
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Table 13 dbSNPs for the RDH12 gene 
SNP Contig 
Accession
5' Flanking       
Sequence 
3' Flanking       
Sequence 
                   
Validation
DNA
         
Chg 
AA 
        
Chg 
Type SNP 
IDd
Status 
in the 
present 
study 
rs2320030 NT_026437 CGTTCAAGGC AAGACTTTAG by-clustera A/G -- intron IVS4+430 not 
detected 
rs718212 NT_026437 GGTGAAATCT TTCCCATTC      by-
frequencyb
C/T -- intron IVS6+539 High 
frequency
rs2009590 NT_026437 TCACTCCTTG TCTGTTGGTC by-cluster C/T -- locus-
region 
-1660 not 
detected 
rs910315 NT_026437 TAATCCACTC TATTTTAAGC by-cluster A/G -- locus-
region 
-437 not 
detected 
rs756473 NT_026437 TGAAAGCCTC GAAATGACCC no-infoc A/G -- intron IVS1+1222 not 
detected 
rs761512 NT_026437 acttctgctc ccactacttt no-info C/G -- intron IVS6-260 High 
frequency
rs4899221 NT_026437 gtgcccagcc TGATAGGCTT no-info C/T -- intron IVS6-865 not 
coveredd
rs4899222 NT_026437 GACTTTTATA TTAGAAAAAA no-info C/T -- intron IVS6-803 not 
coveredd
rs742865 NT_026437 GTACAGGGCT GGAGTGGATA no-info A/G -- locus-
region 
2029 Low 
frequency
rs718213 NT_026437 GTATTTATTC GTGAAGCACT no-info C/T -- intron IVS6+624 not 
detected 
Lower case sequence letters indicate repetitive or low-complexity sequence. 
aBy cluster means that the SNP has been identified by comparison of human ESTs and 
 genomic clones in the public databases. 
bBy frequency means that the SNP has been identified with Allele Frequency data. 
cNo information means that the SNP has been identified without submitting data about its  
 frequency. 
dFor SNP ID definition  see Table 13. 
enot covered because they are just new to dbSNP database. 
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V DISCUSSION 
The retinal pigment epithelium (RPE) is a single cell layer adjacent to the rod and 
cone photoreceptors that plays a key role in retinal physiology and the biochemistry 
of vision. Anatomically, RPE is located between the sensory retina and the choroid, 
this location subsequently exposes the RPE cells to a highly oxidative environment 
due to a high oxygen partial pressure from the underlying choriocapillaris. 
Physiologically, RPE cells phagocytose and digest photoreceptor outer segments. By 
virtue of its location, RPE forms the outer blood-retina barrier, which facilitates the 
selective transport of molecules between the outer neural retina and the choroidal 
blood stream. To meet the diverse and unique tasks in the continual support and 
renewal of the rod and cone photoreceptors, the RPE requires a large number of active 
genes some of which specific to these epithelial cells.  
 
The aim of the present study was to identify and characterize genes expressed 
exclusively or abundantly in the RPE and to assess their contribution to AMD. 
Towards this end, a bovine cDNA library enriched for RPE-specific transcripts was 
constructed in-house using a suppression subtractive hybridization technique. This 
technique normalizes sequence abundance and achieves high enrichement for 
differentially expressed genes. The individual sequences of 2379 cDNAs derived 
from the SSRPE cDNA library were analyzed and querried against sequences 
deposited in GenBank and dbEST databases. This process identified 341 distinct 
genes represented by 1748 ESTs. Some of these have been confirmed to be involved 
in retinal dytrophies such as ABCA4, EFEMP1, RDS, TIMP, VMD2 and RPE65. 
 
1. Candidate gene approach and SNP analysis 
During the last few years, the identification and characterization of disease genes has 
become the main approach to understand the role of specific genes in the pathogenesis 
of inherited disorders. Several strategies have been developed to identify these disease 
genes including the positional cloning and the positional candidate gene strategy. This 
approach allowed the exclusion of several genes as a candidate locus of AMD, VMD2 
(Krämer et al., 2000); EFEMP1 (Guymer et al., 2002); TIMP3 (De La Paz et al., 
1997) and lead to the implication of two genetic factors: the apoE gene (involved in 
the transport of lipids) and the ABCR gene (involved in Stargardt macular dystrophy).  
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Candidate gene approaches can utilize either linkage analysis of highly polymorphic, 
short tandem repeat marker loci in the candidate region, or association of coding or 
noncoding polymorphisms within the candidate genes. The late onset of the disease 
and the fact that AMD is a polygenic and multifactorial complex disease are the main 
limiting factors for linkage analysis studies (Dryja, 1997). Genes expressed in a 
certain tissue can be assumed to be important for the function of that tissue. Once 
isolated, genes that are highly expressed or tissue specific can become candidate 
genes for disorders that affect the tissue used for gene isolation. For example, genes 
expressed in the retina can be candidate genes for retinal disorders.  
 
In order to handle and evaluate the massive amount of data generated by the SSRPE 
cDNA library, a highly efficient and user-friendly database management system was 
developed using Microsoft Access. 
 
2. RDBMS construction 
The development of Access applications requires several steps. The most important 
part of the application process is the development of an efficient and maintainable 
database utilizing logical data modeling and normalization. Normalization simply 
means reducing data to their simplest elements, and only storing each element once. It 
is important to note that most applications fail due to mistakes in analysis and design, 
not because of mistakes’ construction. During design phase of the application 
development process, entities will be used to derive the groupings of data which will 
be physically stored, e.g. tables, record tpyes, and files. For each entity there has to be 
one attribute or a group of attributes which will uniquely identify each occurrence of 
the entity. This attribute (or group of attributes) is the entity’s primary key. For 
example, consider the entity CLONE. The system needs to be able to uniquely 
identify each occurrence of this clone entity. Clone Name can be the primary key as 
for this example, it is not possible for two or more clones to have the same Clone 
name. A clone name will always identify a single clone and eventually a single 
occurrence of the entity CLONE. In some cases, no single attribute is sufficient on its 
own to form the primary key of an entity. In such cases, it has to be considered 
whether there are two or more attributes which together can form the primary key. For 
example, assume the entity CLONE – GENE which contains details of a clone 
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similarity. Each of the attributes on its own is insufficient to act as the primary key of 
the entity. However, attributes Clone Name and Gene ID together will identify an 
individual clone similarity; therefore these two attributes become the primary key of 
the CLONE – GENE entity. In such cases, the primary key is called a compound key 
consisting of two or more attributes, each of which either individually or in 
combination is the primary key of other entities. Both primary and compound keys are 
shown as bold character in the entities and attributes for DBMS. 
 
MS Access is a relational database management system (RDBMS), which stores and 
retrives information according to relationships defined by the analyst. It can help 
organizing data to make it easier to enter, edit, and retrieve the information. With 
Access, tables can be created to contain information, queries to retrieve information 
from tables, and forms and reports to make the information available to users in 
various ways. VBA (Visual Basic for Applications) brings the power of Visual Basic 
to Access application. Access is extremely powerful by itself but occasions arise 
where Access does not have the necessary tools to create some of the features that are 
required by the application. One of the main purposes of a database is to store 
information. Tables, relationships, and other techniques were designed and 
implemented to ensure that the data are maintained in the way that such a database 
requires. However, these data are virtually useless unless we can retrieve the 
information and manipulate it in whatever way needed. A query is a question that can 
be asked in a language called SQL. From a database of genes, we might want to 
know, for example, how many of them are RPE-specific and how many are retina- 
specific. Queries allow us to formulate these questions for the constructed database 
and view the results. It is important to understand that queries do not return tables. 
Rather, they return recordsets. Although they may seem similar, queries and 
recordsets are quite distinct. Queries are the questions we ask the database in SQL 
language; the recordsets are the answers that we get back from the database. An 
effectively designed database will be easier to expand as the requirements of the 
database's information grow and change. For example, at the beginning of this project 
we searched our bovine RPE ESTs sequences against Blast nt, htgs, and dbEST. 
During the course of this project the draft of the human genome was launched to 
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public access (Feburary 2001). Consequently, our database was expanded easily and 
effiencely to accommodate the new developments.  
 
3. SSRPE cDNA library analysis 
To understand the molecular structure and function of the RPE, the relevant subset of 
differentially expressed genes needs to be identified, and studied in detail. The 
identification of the genes expressed in the RPE constitutes a necessary step towards 
the understanding of its physiology. A powerful approach to the analysis of 
expression in a particular tissue or cell type involves single-pass partial sequencing of 
clones from a cDNA library together with the comparative analysis of the resuling 
ESTs with entries in public databases. Because cDNA libraries are typically generated 
from tissues or developmental stages which are randomly selected for sequencing, 
EST representation provides a dynamic view of genome content and expression. EST 
sequencing has been widely used as an efficient approach for gene discovery. It 
should be noted, however, that libraries generated using standard PCR methods to 
include a number of artefacts because of over-cycling of the PCR reaction. Also, such 
libraries may result in an enrichment of small cDNA clones that do not possess the 
entire open reading frame (ORF) of a gene. 
 
To construct a high-quality RPE cDNA library, RPE cells were required in large 
quantities as well as excellent quality, free of any contaminating cells from the 
adjacent retina or the choriod. These requirements can not be met with human RPE. In 
the present study, a PCR-based SSH method (Diatchenko et al., 1996, 1999) for 
cDNA subtraction was performed to isolate and identify mRNAs from bovine RPE. 
This approach normalizes sequence abundance and achieves high enrichment for 
differentially expressed cDNAs by single rounds of subtraction against a mixture of 
cDNAs from several non-ocular tissues (bovine heart and liver). Subsequently the 
expression pattern of individual clones of the RPE cDNA library can be determined. 
RPE clones expressed in RPE and/or retina but not in other tissues are being selected 
for further analysis. Genes expressed in a certain tissue can be assumed to be 
important for the function of that tissue. Clones found to be more highly expressed in 
RPE and/or retina than in other tissues may also choose for further analysis. The 
genes resulting in retinal degeneration which, in some case is a component of a more 
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complex phenotype are typically ubiquitously expressed. For example, mutations in 
TIM3, a widely expressed human gene, lead to Sorsby’s fundus dystrophy that is 
characterized by accumulation of lipid deposits in Bruch’s membrane. (Weber et al., 
1994). De La Paz have excluded the TIMP3 gene as a cause for AMD (De La Paz et 
al., 1997). 
  
In a first phase, 1002 subtracted bovine RPE cDNA clones were sequenced (in-house) 
and blasted to available sequences in the non-redundant GenBank/EMBL and dbEST 
databases. The 1002 bovine RPE-ESTs represent 168 known human genes and 
approximately 107 predicted or as yet unknown genes. Overall, a high degree of 
conservation between bovine and human sequences was noted and was in the range of 
80 to 92% for coding and 70 to 85% for non-coding (mostly 5` or 3` UTRs) regions. 
A detailed comparison of randomly chosen RPE-EST clones 1-200 with RPE clones 
800-1000 demonstrated that the latter sample group still contained a high number of 
novel sequences suggesting that the subtracted  RPE cDNA library was not exploited 
exhaustively, and further bears the potential for the identification of additional novel 
RPE transcripts. In silico expression profiling of the 168 known genes was performed 
to evaluate the SSRPE cDNA library for the degree of enrichment. Data were 
obtained for 153 genes, revealing that about 17% (26/153) of the reported genes were 
RPE and/or retina-specific and around 5% (7/153) were specifically expressed in 
retina and brain. Extrapolating these data has led us to predict that the approximately 
107 unknown genes identified in the first phase of this study could include 15-20 
novel RPE/Retina-specific genes. Northern blot analysis was performed for the 107 
predicted or as yet unknown genes using bovine RNA samples (Faisal Rahman, 
personal communication). The results of the expression have demonstrated that 24 out 
of the 107 clones (23%) analyzed show exclusive or abundant expression in the ocular 
tissues, in particular the RPE and retina. Further analysis of these 24 clones revealed 
that 8 were either redundant clones or show similarity to known genes. The remaining 
16 RPE and/or retina-specific clones representing predicted or as yet unknown genes 
represent excellent candidates for association studies in AMD/control cohorts. Of the 
16 clones, 2 were further characterized in the present study. 
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In a second phase, an additional 1377 subtracted bovine cDNA clones were 
sequenced (Lynkeus) and blasted against a recent release of the human genome draft 
sequence. This raised the total number of the bovine RPE cDNA clones to 2379. 
CAP3 (Huang and Madan, 1999) was used to assemble the high quality sequences of 
all the 2379 ESTs into clusters or singletons. 1.2% of the 2379 RPE-ESTs contains 
vector sequences and was excluded from further analysis. 5% of the RPE-ESTs 
showed homology to multipe chromosomes and were not included in further assembly 
process. The rest of the ESTs (2245) were assembled into 175 contigs and 509 
singletons, which revealed approximately 684 unique genes in the dataset. Of these, 
341 were attributed to known or predicted genes and 343 transcripts did not show 
human orthologues. The frequency of EST distribution after CAP3 analysis and 
BLAST searches showed that most clusters contained 1-3 ESTs and the largest cluster 
contained 151 ESTs (Table 9). 
 
Among the top most abundant ESTs (Table 9) are the genes that have been previously 
shown to be highly expressed in RPE, e.g. the VMD2 gene causing Best vitelliform 
macular dystrophy which is an autosomal dominant disorder (Marquardt et al., 1998; 
Petrukhin et al., 1998) is represented by 151 ESTs. In addition, we assessed the 
validity of the subtracted library by examining ESTs from genes known to be 
specifically expressed in other ocular tissues than the RPE. For example, the genes for 
RHO, RDS, and RCV1 are known to be expressed specifically in the retina playing a 
role in phototransduction, but were found in our library (Table 9). This can be 
considered as retinal contamination of the SSRPE cDNA library; although it may be 
expected as retina and RPE cannot be separated completely. It has been estimated that 
RPE RNA contains 1% retina RNA and vice versa (den Hollander et al., 1999). 
Retinal degeneration might happen because abnormal proteins lead to death of the 
outer segments (OS), but it might also occur because abnormal OS cause damage to 
the RPE after they are phagocytized and digested. The subsequent metabolic damage 
to the RPE may lead to changes that cause further photoreceptors death. In another 
example, Stargardt’s disease is characterized histopathologically by an accumulation 
of lipofuscin-like material throughout the RPE, but the recently isolated ABCA4 gene 
codes for a lipid transporter in the rod outer segments. It seems that the 
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photoreceptors abnormality leads to the accumulation of abnormal material in the 
RPE (Marmor, 1998). 
 
The main reason that about 343 RPE transcripts did not show human orthologues 
might be that these clones might include the 3’ UTR of the gene and not the coding 
regions (Sharma et al., 2002). It is the coding regions that can be conserved between 
bovine and human and not the 3’ UTR. This lacks of human ortholgous can be 
resolved using two approaches. First, continuous blasting might reveal their human 
orthologoues. For example, the clone RPE24-D11 that was found to be RPE specific 
and therefore selected as an AMD candidate gene, used to show no significant 
similarity from May 2002 until March 2003. Recent blast searches (July 2003) 
revealed that clone RPE24-D11 shows similarity to LOC119587 (accession number 
XM_058409). Secondly, more sequencing from the cDNA library together with 
reclustering of those 343 ESTs might reveal their human orthologoues. However, this 
does not mean that all of them are going to be novel, because some of them might 
show similarity (after reclustering) to already reported human genes in the database. 
The quality of the SSRPE cDNA library is reliable and its construction is the basis for 
further screening differentially expressed genes of RPE. Our results show that 
suppression subtractive hybridization (SSH) is a suitable method for identifying rare 
transcripts. 
 
4. Blast searches and gene predictions 
In the present study, genes were identified on the basis of the following criteria: 
identities or similarities to known proteins; identities to spliced ESTs; and patterns of 
consistent coding-exon prediction. First, protein matches identified genes that were 
identical or similar to known genes in the public databases. Secondly, for EST 
matches, only those that showed evidence of splicing were used, those that were non-
contiguous with genomic sequence, showed consensus splice sites, and represented 
essentially perfect matches (>95% identity) to the genomic sequence. Finally, the 
criterion of consistent exon prediction required that two of the coding-exon prediction 
programs (Grail, Genscan) agreed on the location of the exon. 
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5. From genes to functions 
Analysis of the SSRPE cDNA library has provided a first look at the transcriptome of 
this tissue. The next steps require isolating complete cDNAs for each gene. With 
complete coding sequences, protein sequences can be deduced and examined for 
motifs, domains, and biochemical characteristics that may suggest function. The most 
challenging problem will then be to determine the functions of these genes. While it is 
tempting to focus on genes whose protein characteristics suggest a hypothesis for 
relevance to some aspect of AMD or other retina dystrophies, the more than 343 
transcripts identified during the course of this study that have no functional 
association are too large a dataset to ignore. For these and other genes, detailed 
expression analysis may be informative. Completion of the expression analysis 
experiments is in progress using real time RT-PCR and will provide additional 
candidate genes for further analyses. Demonstration that a gene shows increased 
expression in RPE and/or retina by Northern blot or RT-PCR analysis, followed by 
RNA tissue in situ hybridization to define specific cell types and developmental 
stages of expression, may help in selecting genes of greater or lesser interest. 
 
During the course of the present project, we have identified 341 known genes. A 
variety of tools, including BLASTN, BLASTX, LocusLink, SwissProt, Source, Pfam 
and published literature were used for the functional annotation of the known and 
predicted genes. This revealed 18 different functional groups (Figure 22). Of the 341 
known genes, no function could be assigned to 24.4%. In some cases, the lack of 
protein or functional domain data may be due to the lack of complete coding sequence 
information. Genes involved in metabolic pathways are represented and corresponded 
to 14.5% of the total number of annotated genes, although it may be expected as the 
RPE is a highly active metabolic tissue. 12.5% of the known genes involved in 
various types of transport. For instance, SLC6A13 (solute carrier family 6 member 
13) is involved in transport. SLC6A13 is highly expressed in RPE/choroid, and was 
identified in the current library. We also found that 10.3% of the known genes are 
involved in cell-cell signalling, e.g. secreted frizzled-related protein 5 (SFRP5), which 
might act by modulating Wnt signalling transduction and is highly expressed in RPE, 
and is also expressed in pancreas (Jinghua et al., 1999). Recently, it was found that 
disruptions of Wnt network signalling are involved in retinal neurodegeneration, and 
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that targeting of SFRPs to key areas of the neuroretina may mediate mechamisms 
promoting cell death (Jones et al., 2000). 
 
6% of the known genes fall into the cell defence group as RPE is subjected to high 
oxidative stress. This is due to the high partial pressure of oxygen, the high metabolic 
rate of the RPE, accummulation of lipofuscin and chronic light pressure. 
Subsequently, an increase level of reactive oxygen species (ROS) would distrub its 
clearance and result in oxidative damage to macromolecules (Ames et al., 1993; 
Harman, 1998). To cope with these toxic oxygen intermediates, the RPE is protected 
by an effective defence mechanism against oxidative damage. It is particularly rich in 
anti-oxidants such as glutathione-S-transferases, and glutathione (Beatty et al., 2001).  
We identified in our library several antioxidants belonging to multiple isoforms of the 
gene glutathione-S-transferses e.g. GSTM1, GSTM5. 
 
Within the eye, several transcription factors are known to be critical to proper ocular 
development. Transcription factors have been reported to regulate gene expression by 
binding directly to promoter sites within DNA or to other transcription factors 
(Jobling et al., 2002). 4% of the reported genes are involved in transcriptional factors, 
including OTX2 (orthodenticle homolog 2 Drosophila), and NRL (neural retina 
leucine zipper). Among many transcription factors that affect eye morphogenesis, 
OTX2 is of interest, because it is expressed not only at an early stage of eye 
morphogenesis, but also in RPE of postnatal and the adult mouse eye (Baas et al., 
2000). NRL was initially identified as a retina specific and was subsequently shown to 
be expressed throughout the retina cells (Swaroop et al., 1992).  
 
3% of the identified known genes in this study are involved in vitmain A (retinol) 
metabolism and transport, including RPE65, RLBP1, RBP1, LRAT, BCDO1, RBP4, 
and RDH5. RPE has diverse features including the uptake, processing, transport and 
release of vitamin A (retinol) and some of its visual cycle intermediates (retinoids). 
Retinol uptake occurs at both the basolateral and apical surfaces. Delivery of retinol 
across the basolateral membrane is mediated by a retinol binding protein (RBP) that is 
secreted by the liver as a complex with retinol (vitamin A). Within the cell, retinol 
and its derivatives are solubilized by intracellular retinoid binding proteins that are 
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selective for retinol (cellular retinol binding protein, CRBP) and 11-cis retinoids 
(cellular retinal binding protein, CRALBP). 
 
Protein degradation represented 3% of the reported genes; of this 1% are lysosomal 
enzymes. Lysosomal enzymes are responsible for the degradation of a variety of 
proteins, lipids, nucleic acids and complex carbohydrates. Lysosomal enzymes are 
much more active in RPE than in many other tissues of the body and are responsible 
for the degradation of ingested photoreceptor outer segments (Verdugo and Ray, 
1997). Alteration of any of these enzyme activities with aging might be involved in 
the pathogenesis of AMD. 
 
2% of the reported genes are involved in phototransduction. Phototransduction takes 
place in the outer segments of the rod and cone photoreceptor cells. The small 
percentage of photoreceptor-specific genes in the RPE could be considered as 
contamination of the RPE with retina.  
 
The known genes identified in this RPE library reflect our knowledge of RPE 
physiology and may facilitate better understanding of human macular degeneration. It 
is expected that the unknown transcripts will also shed further light on the function 
and physiology of this important ocular tissue. 
 
6. Comparison to similar studies 
EST analysis of a cDNA library is a powerful tool for probing the transcriptome of 
tissues and cell types. There are two approaches for cDNA libraries construction 
either un-amplified and unnormalized or amplified and subtracted. On one hand, the 
unamplified and unnormalized cDNA library is constructed to have as close as 
possible a representation of normal transcript abundance, maximize clone length and 
to allow the discovery of difficult clones that might disappear during library 
manipulation (Wistow et al., 2002b). On the other hand, cDNA library is amplified 
and subtracted to equalize the abundance of cDNA within the target populations and 
exclude the common sequences between the target and driver population (Diatchenko 
et al., 1996; 1999). At the initiation of the present project (May 2000), only two 
studies reported the identification of RPE-specific genes using subtracted cDNA 
                                                                                                                                        Discussion    
 
 
84
 
libraries from human RPE-cell line (Gieser and Swaroop, 1992) and human RPE and 
choroid (den Hollander et al., 1999). Since then and during the course of the current 
project, other similar studies have been reported (Sharon et al., 2002; Buraczynska et 
al., 2002; Wistow et al., 2002a; Sharma et al., 2002). Of the approximately estimated 
10000 transcripts in the mammalian RPE (Swaroop and Zack, 2002), only 1-2% are 
estimated to be unique or differentially expressed transcripts (Zhang et al., 1997). The 
transcripts that specifically or differentially expressed in the human RPE may be 
estimated to be about 100-200. 
 
Sharma et al. reported sequencing and analysing of 1000 clones from a subtracted 
bovine RPE cDNA library (Sharma et al., 2002). Northern blot analysis was 
performed for 100 non redundant clones. 45 of the clones gave positive hybridization, 
and 2 of these 45 were present in duplicate and excluded from further analysis. 19 of 
the remaining 43 clones showed homology to known mammalian genes, whereas 24 
of them showed no matches to any known gene. Comparison of the results of 
Northern blot analysis of 91 non redundant clones from the Sharma library to the 107 
predicted genes from our SSRPE library revealed the tissue distribution of 50% of the 
cDNA clones (Table 14). Expression of half of the subtracted cDNAs was not 
detectable under the conditions of Northern hybrization used in both studies, possibly 
suggesting a low level of expression of their respective transcripts (Table 14). 
Northern blot analysis of poly-A+ RNA may reveal the transcipts and tissue 
distribution of these cDNAs (Sharma et al., 2002). The expression analysis 
demonstrated that the subtractive hybridization method used in both studies enabled 
the enrichment of genes expressed in the bovine RPE.  
 
Wistow et al. reported that unamplified, un-normalized RPE/choroid (Wistow et al., 
2002a) and retina (Wistow et al., 2002b) library reveal an abundantly expressed 
genes. These libraries also revealed cDNAs that may be selectively lost through 
library manipulations such as amplification because of poor growth characteristics in 
bacterial hosts (Wistow et al., 2002b). The normalized version of the same libraries 
loses abundance information, but has the potential for identification of the rarer 
transcripts. 
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Table 14 Summary of the expression of 107 SSRPE cNDAs and 91 subtracted bovine 
cDNAs from the Sharma RPE library 
Tissue specificity       SSRPEa   Sharmab 
RPE-specific      7   11 
Retina-specific     3   13 
RPE/retina specific     7   11 
Tissue-restricted     7   7  
Ubiquitous      29   3 
No possible evaluation    54c   46c 
 
Total       107   91  
aData provided by Faisal Rahman (Personal commincation, 2002). 
bSharma et al., 2002 
cExpression of about half of the subtracted RPE cDNAs was not detectable under the 
conditions of Northern blot hybridization possibly suggesting a low level of 
expression. 
 
Wistow et al. (2002a) generated 10,000 ESTs from the human RPE/choroid for the 
NEIBank project. The NEIBank database was created by the National Eye Institute 
(Wistow, 2002c; http://neibank.nei.nih.gov/index.shtml). Comprehensive analysis of 
the NEIBank RPE/choroid unique gene clusters revealed that 3820 attributed to 
known genes in the public databases and the rest of 2480 have no matches. 
Comprehensive comparison of the 3820 unique RPE clusters with our datasets of 341 
RPE known genes shows that only 146 are overlapping between the two libraries 
(Table 10 & Figure 23). 42.8% of our identified RPE genes are overlapping with only 
3.8% of NEIBank RPE/choroid known genes. This result is not surprising, as the 
NEIBank genes are from combined RPE and choroid, many transcripts might have 
been derived from ocular vasculature (Wistow et al., 2002a). In addition, the 
RPE/choroid library was an unamplified and unnormalized library, whereas our 
cDNA library is subtracted, suggesting that many of these 3820 uniquie RPE could be 
house-keeping genes.  
 
Further analysis of the 146 overlapping genes shows that 11 of them are involved in 
retinal dystrophy (shown as bold and underlined in Table 10). For example, the EGF-
containing fibrillin-like extracellular matrix protein-1 (EFEMP1) gene is associated 
with Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD) 
(Stone et al., 1999). ML and DHRD refer to two autosomal dominant diseases 
characterized by yellow-white deposits known as drusen that accumulate beneath the 
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RPE. The EFEMP1 gene is expressed in the retina, RPE and choroid and shows 
homology to a family of extracellular matrix glycoproteins known as fibulins. The 
Arg345Trp disease-associated allele of the EFEMP1 gene has been excluded from 
been associated with AMD etiology (Guymer et al., 2002). However, this does not 
exclude the involvement of other alleles of the EFEMP1 gene in the AMD phenotype. 
 
7. Cloning and characterization of RPE01-D2 and RPE6-C10 
As was mentioned previously, 16 RPE and/or retina-specific clones representing 
predicted or as yet unknown genes, were selected as AMD candidate genes. To 
further evaluate these clones extensive homology searches for protein motifs and 
assignment to established protein families have been performed. This resulted in 
cloning and characterization of two clones, RPE01-D2 and RPE06-C10.  
 
7.1 RPE01-D2 
The clone RPE01-D2 was identified from our subtracted RPE cDNA library and 
found to show similarity to exon 4 and exon 5 of the human LOC145226 (later 
FLJ30273, now RDH12, accession number NM_152443). RPE01-D2 was found 
using Northern blot hybridization to be expressed in bovine retina and RPE with 
abundant expression in retina, but not in other bovine tissues examined. The retina 
specificity of LOC145255 was further confirmed by RT-PCR analysis in adult human 
tissues.  
 
Amino acid sequence comparisons of RDH12 to known proteins in the database 
indicate significant homology to the short-chain dehydrogenases/reductases (SDR). 
The SDR is a very large family of enzymes, most of which are known to be NAD- or 
NADP-dependent oxidoreductases (Joernvall et al., 1995). Most members of this 
family are proteins of about 250 to 300 amino acid residues. The amino acid sequence 
of RDH12 contains two motifs highly conserved among the SDRs superfamily, the 
cofactor-binding site (GXXXGXG) and catalytic residues (YXXXK). The first binds 
the coenzyme, often NAD, and the second binds the substrate. The latter domain 
determines the substrate specificity and contains amino acids involved in catalysis. 
Recently, strong signals of the RDH12 transcript in photoreceptor inner segments of 
monkey and mouse retina has been detected using in situ hybridiation (Haeseleer et 
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al., 2002). Although the function of RDH12 is at this point unclear, it was suggested 
that it could be involved in the formation of 11-cis retinal from 11-cis retinol during 
regeneration of the cone visual pigments (Haeseleer et al., 2002).  
 
The RDH12 gene maps to chromosome 14q23.3 and is located 30 kb from the RDH11 
gene in the 3’-RDH11-5’ 5’-RDH12-3’ orientation. RDH12 and RDH11 genes are 
located at the locus for an autosomal recessive retinal distrophy, Leber’s congenital 
amaurosis 3 (LCA3). This autosomal recessive disorder is usually recognized at birth 
or during the first months of life in an infant with total blindness or impaired vision. 
Recently, mutations in three genes have been associated with LCA phenotype. These 
include a retinal-specific guanylate cyclase (Perrault et al., 1996); RPE65 (Marlhens 
et al., 1997); and CRX (Freund et al., 1998). Additionally, several recent studies have 
suggested that LCA is genetically heterogeneous and still there are genes remain to be 
identified for this disease (Stockton et al., 1998 ; Hameed et al., 2000). Mutations in 
CRALBP have been linked to cases of autosomal recessive retinitis pigmentosa (Maw 
et al., 1997); and mutations in 11-cis-retinol dehydrogenase have been reported in 
patients with fundus albipunctatus (Yamamoto et al., 1999). RDH12 could be 
considered as a candidate gene for AMD and other retinal dystrophies due to the fact 
that many retinal degeneration have been associated with mutations in genes involves 
in the visual cycles and retinoid metabolism. 
 
7.2 RPE06-C10 
6-C10 is an intronless gene and thus far has not been annotated in the Human Genome 
Sequence draft (Build 33). Northern blot analysis using RPE06-C10 clone as a probe 
and bovine RNA samples revealed that it is highly expressed in RPE and weakly in 
retina, but not in other tissues examined. The retina and RPE specificity was further 
confirmed by RT-PCR analysis in adult human tissues. In addition, this gene was also 
found to be expressed in human lung. 
 
This intronless gene is GC-rich and represents a highly conserved sequence between 
human, mouse and rat. GC rich sequences can be difficult to amplify by PCR. 6-C10 
was amplified using 2X PCRx Enhancer solution and 3 pairs of overlapping primers 
that cover the entire length of the single exon gene. Because of its highly GC-rich, 6-
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C10 illustrates some of the features that may be common to other genes that are 
missing from the current builds of the human genome, making it difficult for reverse 
transcription and for growth in bacterial host cells (Wistow et al., 2002a). 
 
The genomic organization of the 6-C10 was investigated by performing PCR 
amplification on genomic DNA template, using the 3 sets of oligonucleotide pairs 
encompassing the 5` and 3` ends of the 6-C10 mRNA transcript. The size of the 
resulting PCR products coincided with that of the 6-C10 cDNA used as template, 
demonstrating that cDNA was corresponding in full to the genomic DNA suggesting 
that 6-C10 is an intronless gene. A single long open reading frame of 1149 bases was 
identified, encoding a putative protein of 383 amino acids. It is noteworthy that the 
coding exons of intronless genes tend to be very large generally encompassing more 
than one kilobase (kb) in length, in contrast to typical coding exons that average 100-
150 bp. From the large open reading frame of 6-C10, a protein of 383 amino acids 
was deduced, with a predicted molecular mass of 40.4 kDa.  Amino acid sequence 
comparisons to known proteins in the database indicate significant homology to 3 
leucine rich repeats (LRR) and one LRR C-terminal domain (LRRCT). LRR domains 
are short sequence motifs present in a number of proteins with diverse functions and 
cellular locations. LRRs are often flanked by cysteine rich domains. This domain is 
often found at the C-terminus of tandem leucine rich repeats. LRR proteins have been 
reported in various species with diverse functions and proteins belonging to the LRR 
superfamily are thought to be involved in specific protein-protein and protein-matrix 
interactions (Buchanana and Gay, 1996). Recently, a novel β-Amyloid-induced (Aβ) 
rat and human gene, designated as Lib and LRRC15 respectively, suggests to be a 
member of the LRR superfamily which is involved in cell-cell and/or cell-
extracellular matrix interactions including adhesion or target recognition in 
neuroinflammation states (Satoh et al., 2002). The availability of a mouse orthologue 
of the 6-C10 gene makes its functional analysis feasible through the generation of 
transgenic mice. 
 
8. Generation of a SNP map of RPE01-D2 (RDH12) 
Genotyping involves the analysis of genomic DNA to identify naturally occurring 
differences between individuals. These DNA differences, referred to as 
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polymorphisms, can be used as “molecular signposts” to locate genes involved in the 
development of complex diseases such as diabetes, asthma, or AMD. Disease genes 
are identified by defining genetic linkage between polymorphisms and the distribution 
of disease within affected populations. A statistically significant link between known 
polymorphisms and the disease indicates that a disease-contributing gene is located 
within the same chromosomal region of the polymorphism. Thus, genotyping 
facilitates gene identification for drug target discovery and identification of diagnostic 
markers. 
 
In addition to SNP genotyping, a novel approach to SNP haplotyping is the process of 
determining the presence of linked SNPs. Haplotypes result from the simultaneous 
presence of two or more DNA variations or SNPs that are genetically linked. 
Haplotyping is gaining increased attention because multiple linked SNPs have the 
potential to provide significantly more power for genetic analysis than individual 
SNPs. Thus, haplotype tag SNPs (htSNPs) may be used more efficiently for disease 
association studies to compare the genomes of diseased populations to matched 
control populations, and are expected to be more useful as diagnostic or predictive 
markers than individual SNPs. 
 
In the present study, the identification of SNPs in the RDH12 locus was achieved by 
direct sequencing and dHPLC scanning. The main focus of SNP identification was 
within the coding region and exon/intron boundaries of the gene, as well as 5 kb 
upstream and downstream of the 5´ and 3´ UTRs, respectively. 12 SNPS were 
identified from direct sequencing of the 23.4-kb region, of which only 5 are of high 
frequency and were identified in intronic regions of RDH12. However, before any 
conclusions can be made, comparison of allele frequencies between patients with 
AMD phenotype and healthy controls is required.  
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VI CONCLUSIONS AND FUTURE DIRECTIONS 
 
AMD is the leading cause of severe central visual impairment among the elderly and 
is associated both with environmental and genetic factors. Identification of the 
conferring susceptibility to AMD will facilitate an early diagnosis of the disease and 
may lead to the development of new strategies for prevention and therapy. 
 
Although the generation of ESTs constitutes an efficient strategy to identify genes, 
there are some limitations to their approach. Firstly, it is difficult to isolate mRNA 
from some tissues and cell types. This results in a paucity of data on certain genes that 
may only be found in these tissues or cell types. However, this problem has been 
resolved in the present study by using bovine instead of human RPE. Secondly, 
important gene regulatory sequences may be found within an intron. Because ESTs 
are small segments of cDNA, generated from an mRNA in which the introns have 
been removed, much valuable information may be lost by focusing only on cDNA 
sequencing. Despite these limitations, the present study demonstrated that ESTs are 
invaluable in characterizing the human genome, as well as the genomes of other 
organisms. They have enabled the mapping of many genes to chromosomal sites and 
have also assisted in the discovery of many new genes. In this EST project, we used a 
simple and more direct approach to assess the RPE transciptome. Both in silico 
analysis and experimental data provided evidence that the SSRPE cDNA library is 
indeed enriched, indicating the high efficiency of the cDNA subtraction strategy. 
 
The combination of bioinformatics analysis and laboratory investigation is an 
effective approach for the identification of candidate genes that are specifically or 
abundantly expressed in tissue-restricted manner (e.g. RPE/retina). Using genetic 
association studies, the contributions of individual genes to complex diseases that 
have a polygenetic basis like AMD, can be identified. By comparing frequency of 
SNPs in patients and controls, genes that contribute to disease can be determined. The 
future goal of this project is to develop comprehensive SNP maps of RPE-associated 
genes to enable extensive AMD case/control association studies.  
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APPENDIX 
1.  ESTs representing known genes in the SSRPE cDNA library classified by function 
Gene Name (Gene symbol)     Accession Number        Frequency         
Cell defence 
ATX1 antioxidant protein 1 homolog (yeast) (ATOX1)         NM_004045                1 
Glutathione S-transferase M5 (GSTM5)         NM_000851                2 
Glutathione S-transferase M (GSTM)         NM_000850                44 
BCL2-like 1 (BCL2L1)          NM_138578                3 
Eukaryotic translation elongation factor 1 epsilon 1(EEF1E1)         NM_004280                1 
Monoamine oxidase B MAOB         NM_000898                18 
BCL2/adenovirus E1B 19kDa interacting protein 2 (BNIP2)         NM_004330                  1 
Microsomal glutathione S-transferase 1 (MGST1)         NM_145791                3 
Melanoma antigen, family D, 1 (MAGED1)         NM_006986                1 
Forkhead box O1A (rhabdomyosarcoma) (FOXO1A)         NM_002015                1 
Requiem, apoptosis response zinc finger gene (REQ)         NM_006268                1 
Glutathione peroxidase 4 (phospholipid hydroperoxidase) (GPX4)         NM_002085                3 
Defender against cell death 1 (DAD1)         NM_001344                1 
Testis enhanced gene transcript (BAX inhibitor 1) (TEGT)         NM_003217                2 
Apoptosis related protein (APR-3)         NM_016085                5 
Glucose phosphate isomerase (GPI)         NM_000175                2 
Heat shock 90kDa protein 1, beta (HSPCB)         NM_007355                   1 
Peroxiredoxin 1 (PRDX1)          NM_002574                3 
Peroxiredoxin 2 (PRDX2)          NM_005809                4 
Clusterin (CLU)          NM_001831                6 
 
Cell division 
Likely ortholog of mouse septin 8 (SEPT8)                                                              XM_034872                  1 
Cyclin-dependent kinase 2  (CDK2)                                                                         NM_001798                        1 
LAG1 longevity assurance homolog 2 (S. cerevisiae) (LASS2)                               NM_013384                        1 
Growth differentiation factor 11 (GDF11)                                                                 NM_005811                        1 
 
Cell structure/maintenance  
Centaurin, delta 2 (CENTD2) NM_139181              1 
Component of oligomeric golgi complex 5 (COG5) NM_006348              1 
Component of oligomeric golgi complex 7 (COG7) NM_153603              1 
Ectonucleotide pyrophosphatase/phosphodiesterase 2  (ENPP2) NM_006209              2 
Ferritin, heavy polypeptide 1 (FTH1) NM_002032              4 
Skeletal muscle and kidney enriched inositol phosphatase (SKIP) NM_016532              15 
Solute carrier family 9 (sodium/hydrogen exchanger),  
isoform 3 regulatory factor 1 (SLC9A3R1) NM_004252              1 
CLIP-170-related protein (CLIPR-59)  NM_015526              1 
Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) (SPTAN1) NM_003127              1 
Histone 2, H2be (HIST2H2BE) NM_003528              1 
Serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin,  
pigment epithelium derived factor), member 1 (SERPINF1)  NM_002615              1 
Dynein light chain 2  (Dlc2) NM_080677              1 
Myeloid leukemia factor 2 (MLF2) NM_005439              1 
Myosin, light polypeptide 6, alkali, smooth muscle and non-muscle (MYL6) NM_079425              2 
Tubulin, gamma 1 (TUBG1) NM_001070              1 
Protease, serine, 11 (IGF binding)  (PRSS11) NM_002775              6 
Histone 1, H2bd (HIST1H2BD) NM_138720              1 
 
Cell-cell signalling  
Sparc/osteonectin, cwcv and kazal-like domains proteoglycan ((SPOCK) NM_004598              6 
V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (SRC) NM_005417              2 
Secreted frizzled-related protein 5  (SFRP5) NM_003015              1 
Transforming growth factor, beta-induced, 68kDa  (TGFBI) NM_000358              1 
Coagulation factor II (thrombin) receptor-like 2 (F2RL2) NM_004101              1 
FLN29 gene product (FLN29) NM_006700              2 
Flotillin 2 (FLOT2)  NM_004475              1 
Gamma-aminobutyric acid (GABA) receptor, rho 2 (GABRR2) NM_002043              2 
Gap junction protein, beta 1, 32kDa (connexin 32,  
Charcot-Marie-Tooth neuropathy, X-linked) (GJB1) NM_000166              1 
Shroom-related protein (ShrmL) NM_020859              1 
Dual specificity phosphatase 6 (DUSP6) NM_001946              1 
Secreted frizzled-related protein 2 (SFRP2) XM_050625              4 
MT-protocadherin  (KIAA1775) NM_033100              1 
RYK receptor-like tyrosine kinase (RYK) NM_002958              1 
Retinal degeneration, slow (retinitis pigmentosa 7) (RDS) NM_000322              10 
Natriuretic peptide receptor B/guanylate cyclase B (NPR2) NM_000907              1 
protocadherin gamma subfamily A, 5 (PCDHG@) NM_002588               1 
Pygopus 2  (PYGO2)  NM_138300              1 
Seven in absentia homolog 2 (Drosophila)  (SIAH2) NM_005067              1 
Ras homolog gene family, member C  (ARHC) NM_005167              1 
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Gene Name (Gene symbol)     Accession Number        Frequency         
Transmembrane 4 superfamily member 2  (TM4SF2) NM_004615              5 
Syndecan 4 (amphiglycan, ryudocan) (SDC4) NM_002999              1 
Cadherin 3, type 1, P-cadherin (placental)  (CDH3) NM_001793              68 
Tetraspan 3  (TSPAN-3)  NM_005724              5 
Ortholog of mouse mitogen activated protein kinase binding protein 1 (MAPKBP1) XM_031706              1 
Basigin (OK blood group)  (BSG) NM_001728              1 
Mitogen-activated protein kinase kinase 1 (MAP2K1) NM_002755              1 
G protein-coupled receptor, family C, group 5, member B (GPRC5B) NM_016235              3 
Colony stimulating factor 1 receptor, formerly McDonough feline  
sarcoma viral (v-fms) oncogene homolog (CSF1R) NM_005211              2 
Guanine nucleotide binding protein (G protein), beta polypeptide 3 (GNB3) NM_002075              1 
Guanine nucleotide binding protein (G protein), alpha transducing  
activity polypeptide 1  (GNAT1) NM_144499              5 
Vascular endothelial growth factor  (VEGF) NM_003376              2  
Active BCR-related gene (ABR) NM_021962              4 
Guanine nucleotide binding protein (G protein), gamma transducing  
activity polypeptide 1  (GNGT1) NM_021955              3 
 
Development  
Bone morphogenetic protein 7 (osteogenic protein 1) (BMP7) NM_001719              2 
Protein tyrosine phosphatase-like member a (PTPLA NM_014241              1 
Frizzled-related protein (FRZB) NM_001463              7 
 
Energy metabolism 
Acetyl-Coenzyme A synthetase 2 (ADP forming) (ACAS2)      NM_018677               1 
Creatine kinase, mitochondrial 1 (ubiquitous) (CKMT1)      NM_020990               5 
Cytochrome c oxidase subunit IV isoform 1 (COX4I1)      NM_001861               1 
ytochrome c oxidase subunit VIIc (COX7C)         NM_001867               1 
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c  
(subunit 9), isoform 2 (ATP5G2)        NM_005176               1 
ATP synthase, H+ transporting, mitochondrial F1 complex,  
beta polypeptide (ATP5B)        NM_001686               1 
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit g (ATP5L)   NM_006476               1 
Similar to citrate synthase precursor; Citrate synthase,  
mitochondrial (LOC284438)        XM_209202               1 
Optic atrophy 3 (autosomal recessive, with chorea and spastic  
paraplegia) (OPA3)         NM_025136               1 
(LOC136234)                       1 
Cytochrome c oxidase subunit VIII (COX8)       NM_004074               2 
Acetyl-Coenzyme A acyltransferase 2 (ACAA2)      NM_006111               1 
 
Extracellular matrix maintenance 
procollagen C-endopeptidase enhancer 2 (PCOLCE2)     NM_013363               1 
Tissue inhibitor of metalloproteinase 2 (TIMP2)       NM_003255               2 
Tissue inhibitor of metalloproteinase 3 (Sorsby fundus dystrophy,  
pseudoinflammatory) (TIMP3)       NM_000362               5 
EGF-containing fibulin-like extracellular matrix protein 1(EFEMP1)    NM_004105               2 
Fibromodulin (FMOD)        NM_002023              18 
 
Lysosomal enzyme 
Cathepsin K (pycnodysostosis) (CTSK)       NM_000396               1 
Sulfatase 1 (SULF1)        NM_015170               1 
 
Metabolism 
like-glycosyltransferase (LARGE)       NM_004737               3 
Protein phosphatase 1B (formerly 2C), magnesium-dependent,  
beta isoform (PPM1B)        NM_002706              1 
Phospholipase A2, group V (PLA2G5)       NM_000929              2 
Triosephosphate isomerase 1 (TPI1)       NM_000365              3 
Thiamin pyrophosphokinase 1 ( TPK1)       NM_022445              1 
Lactate dehydrogenase B; (LDHB)       NM_002300              1 
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase,  
polypeptide 1 (B4GALT1)        NM_001497              1 
Phosphatidylserine synthase 1 (PTDSS1)      NM_014754              1 
Tyrosinase-related protein 1 (TYRP1)       NM_000550              2 
Pipecolic acid oxidase (PIPOX)       NM_016518              8 
Microsomal NAD+-dependent retinol dehydrogenase 4 (RODH-4)    NM_003708              1 
Phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1)   NM_002766              1 
Phospholipase A2, group VII (platelet-activating factor acetylhydrolase,  
plasma) (PLA2G7)         NM_005084               3 
Plasma glutamate carboxypeptidase (PGCP)      NM_016134               2 
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Gene Name (Gene symbol)     Accession Number        Frequency         
Peroxisomal biogenesis factor 11B (PEX11B)      NM_003846                 1 
Pyruvate dehydrogenase kinase, isoenzyme 2 (PDK2)      NM_002611                 8 
Isocitrate dehydrogenase 3 (NAD+) beta (IDH3B)      NM_174856                 3 
ADP-ribosyltransferase 3 (ART3)       NM_001179                 1 
Aldo-keto reductase family 1, member A1 (aldehyde reductase) (AKR1A1)   NM_006066  1 
Dehydrogenase/reductase (SDR family) member 4 (DHRS4)    NM_021004  3 
Isocitrate dehydrogenase 3 (NAD+) gamma (IDH3G)     NM_174869  2 
Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3,  
yeast)-like 2 (ELOVL2)        NM_017770   3 
Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3,  
yeast)-like 1 (ELOVL1)        NM_022821  7 
Sphingomyelin phosphodiesterase 1, acid lysosomal (acid sphingomyelinase) 
(SMPD1)          NM_000543  2 
Pleckstrin homology domain containing, family A (phosphoinositide binding  
specific) member 1 (PLEKHA1)       NM_021622  1 
Cystatin C (amyloid angiopathy and cerebral hemorrhage) (CST3)    NM_000099  19 
Enhancer of rudimentary homolog (Drosophila) (ERH)     NM_004450  2 
Glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate  
aminotransferase 2)  (GOT2)        NM_002080  1 
Fatty acid desaturase 1 (FADS1)       NM_013402  1 
Deoxyhypusine synthase (DHPS)       NM_001930  1 
Sulfite oxidase (SUOX)        NM_000456  2 
Dolichyl-diphosphooligosaccharide-protein glycosyltransferase (DDOST)   NM_005216  1 
Dimerization cofactor of hepatocyte nuclear factor 1 ( HNF1) from muscle  
(DCOHM)          NM_032151  1 
Glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) 
(GOT1)          NM_002079  1 
Glutamate-ammonia ligase (glutamine synthase) (GLUL)     NM_002065  5 
Dolichyl-phosphate mannosyltransferase polypeptide 2, regulatory subunit 
(DPM2)          NM_152690  2 
Carbonic anhydrase XII (CA12)       NM_001218  1 
Hydroxyacyl-Coenzyme A dehydrogenase, type II (HADH2)     NM_004493  1 
Succinate dehydrogenase complex, subunit B, iron sulfur (Ip) (SDHB)    NM_003000  5 
Vitamin A responsive; cytoskeleton related (WA)      NM_006407  3 
Hydroxysteroid (17-beta) dehydrogenase 8 (HSD17B8)     NM_014234  1 
Isovaleryl Coenzyme A dehydrogenase (IVD)      NM_002225  2 
Emopamil binding protein (sterol isomerase) (EBP)     NM_006579  1 
Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (SDHA)   NM_004168  5 
Glyceraldehyde-3-phosphate dehydrogenase (GAPD)     NM_002046  5 
Carbonic anhydrase XI (CA11)       NM_001217  2 
Carbonic anhydrase XIV (CA14)       NM_012113  27 
Spermidine/spermine N1-acetyltransferase (SAT)      NM_002970  1 
Solute carrier family 20 (phosphate transporter), member 1 (SLC20A1)   NM_005415  2 
Ceroid-lipofuscinosis, neuronal 2, late infantile (Jansky-Bielschowsky disease) 
(CLN2)          NM_000391  3 
Stromal cell-derived factor 2 (SDF2)       NM_006923  2 
 
Neuron growth and function 
Olfactomedin 1 (OLFM1)        NM_014279  1 
Putative small membrane protein (NID67)       NM_032947  1 
Erythrocyte membrane protein band 4.1-like 1 (EPB41L1)     XM_047295  2 
Neuronal proteinv(NP25)        NM_013259  1 
Glycoprotein M6A (GPM6A)        NM_005277  1 
Glycoprotein M6B (GPM6B)        NM_005278  12 
Spastic ataxia of Charlevoix-Saguenay (sacsin) (SACS)     NM_014363  1 
 
Phagocytosis 
c-mer proto-oncogene tyrosine kinase (MERTK)      NM_006343  1 
 
Phototransduction 
rhodopsin (opsin 2, rod pigment) (retinitis pigmentosa 4, autosomal  
dominant) (RHO)                                                                                          NM_000539                37 
unc-119 homolog (C. elegans) (UNC119) NM_054035                7 
Sine oculis homeobox homolog 3 (Drosophila) (SIX3) NM_005413                5 
S-antigen; retina and pineal gland (arrestin) (SAG)  NM_000541                1 
Recoverin  (RCV1)  NM_002903                18 
Pleckstrin homology domain containing, family B (evectins) member 1  
(PLEKHB1)  NM_021200                5 
ATP-binding cassette, sub-family A (ABC1), member 4 (ABCA4) NM_000350                3 
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Gene Name (Gene symbol)     Accession Number        Frequency         
Protein degradation 
protein degradation; homocysteine-inducible, endoplasmic reticulum 
stress-inducible, ubiquitin-like domain member 1 (HERPUD1)    NM_014685  1 
Protein degradation; SMT3 suppressor of mif two 3 homolog 1  
(yeast) (SMT3H1)         NM_006936  1 
Ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivity  
complementing)  (UBE1)        NM_003334  1 
26S proteasome-associated pad1 homolog (POH1)      NM_005805  1 
Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast) (UBE2M)   NM_003969  1 
Ring finger protein 25 (RNF25)       NM_022453  1 
 
Vitamin A metabolism/transport 
Lecithin retinol acyltransferase  (LRAT)       NM_004744  33 
Retinal pigment epithelium-specific protein 65kDa  (RPE65)     NM_000329  52 
Retinal G protein coupled receptor (RGR)      NM_002921  37 
Beta-carotene 15, 15'-dioxygenase (BCDO1)      NM_017429  13 
Retinol dehydrogenase 5 (11-cis and 9-cis) (RDH5)     NM_002905  1 
Retinol dehydrogenase 12 (all-trans and 9-cis) (RDH12)     NM_152443  5 
Retinol dehydrogenase 10 (all-trans) (RDH10)      NM_172037  35 
Retinol binding protein 4, plasma (RBP4)      NM_006744  1 
Retinol binding protein 1, cellular (RBP1)      NM_002899  7 
Retinaldehyde binding protein 1 (RLBP1)      NM_000326  63 
 
Transcription factor 
Eukaryotic translation initiation factor 3, subunit 2 beta, 36kDa (EIF3S2)   NM_003757  1 
Orthodenticle homolog 2 (Drosophila) (OTX2)        NM_021728  3 
Sex comb on midleg homolog 1 (Drosophila) (SCMH1)     NM_012236  2 
Fragile X mental retardation 2 (FMR2)       NM_002025  1 
Basic helix-loop-helix domain containing, class B, 2 (BHLHB2)    NM_003670  1 
Trinucleotide repeat containing 15  (TNRC15)      XM_209467  78 
Enhancer of zeste homolog 1 (Drosophila) (EZH1)     NM_001991  1 
Pilin-like transcription factor  (PILB)       NM_012228  1 
AE binding protein 1 (AEBP1)        NM_001129  1 
Likely ortholog of mouse gene trap locus 3 (GTL3)     NM_013242  2 
Transforming growth factor beta-stimulated protein (TSC22)     NM_006022   1 
Putative DNA/chromatin binding motif (PLU-1)      NM_006618  1 
SRB7 suppressor of RNA polymerase B homolog (yeast) (SURB7)    NM_004264  1 
Neural retina leucine zipper (NRL)       NM_006177  2 
 
Transport 
Solute carrier family 16 member 1 (SLC16A1)       NM_003051  1 
Coatomer protein complex, subunit alpha ( COPA)     NM_004371  1 
Solute carrier family 13, member 3 (SLC13A3)      NM_022829  2 
Solute carrier family 21, member 14 (SLC21A14)       NM_017435  1 
Solute carrier family 22 (organic anion transporter), member 8 (SLC22A8)   NM_004254  2 
Solute carrier family 24, member 1 (SLC24A1)      NM_004727  1 
RAB7, member RAS oncogene family (RAB7)       NM_004637  1 
Solute carrier family 1 (glutamate transporter), member 7 (SLC1A7)    NM_006671  5 
Low density lipoprotein-related protein 1B (deleted in tumors) (LRP1B)   NM_018557  1 
Solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier),  
member 11 (SLC25A11)        NM_003562  1 
Solute carrier family 2 (facilitated glucose transporter), member 1 (SLC2A1)   NM_006516  35 
X transporter protein 3 (XT3)        NM_020208  36 
Solute carrier family 41, member 1 (SLC41A1)      NM_173854  3 
Serum/glucocorticoid regulated kinase; (SGK)       NM_005627  1 
Solute carrier family 4, sodium bicarbonate cotransporter, member 5 (SLC4A5)    NM_033323  22 
Solute carrier family 6, member 13(SLC6A13)      NM_016615  8 
RAB5B, member RAS oncogene family (RAB5B)      NM_002868  1 
Sorting nexin 5 (SNX5)        NM_152227  2 
Member RAS onocogene family (RAB15)       XM_085123  1 
Phosphotidylinositol transfer protein (PITPN)      NM_006224  1 
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 (ABCC5)   NM_005688  4 
Syntaxin binding protein 1 (STXBP1)       NM_003165  2 
Solute carrier family 38, member 3 (SLC38A3)      NM_006841  1 
ATPase, H+ transporting, lysosomal V0 subunit a isoform 1 (ATP6V0A1)   NM_005177  8 
Myosin VIIA and Rab interacting protein (MYRIP)      NM_015460  1 
LAT1-3TM protein (LAT1-3TM)        NM_031211  1 
Myosin VA (heavy polypeptide 12, myoxin) (MYO5A)     NM_000259  1 
Transmembrane 9 superfamily member 1 (TM9SF1)     NM_006405  1 
ATP-binding cassette, sub-family G (WHITE), member 2 (ABCG2)    NM_004827  1 
Importin 13 (IPO13)        NM_014652  1 
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Gene Name (Gene symbol)     Accession Number        Frequency         
Similar to Na-Ca exchanger 5 [Mus musculus] (LOC283652)    XM_208771  3 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9kDa (NDUFA4)   NM_002489  1 
Transient receptor potential cation channel, subfamily M, member 1 (TRPM1)   NM_002420  13 
Transient receptor potential cation channel, subfamily M, member 3 (TRPM3)   NM_020952  79 
ATPase, Na+/K+ transporting, beta 2 polypeptide (ATP1B2)     NM_001678  17 
ATPase, Na+/K+ transporting, alpha 3 polypeptide (ATP1A3)    NM_152296  2 
Transthyretin (prealbumin, amyloidosis type I) (TTR)     NM_000371  87 
ADP-ribosylation factor-like 3 (ARL3)       NM_004311  1 
ATPase, H+ transporting, lysosomal 21kDa, V0 subunit c'' (ATP6V0B)   NM_004047  4 
Potassium inwardly-rectifying channel, subfamily J, member 10 (KCNJ10)   NM_002241  1 
Adaptor-related protein complex 1, sigma 2 subunit (AP1S2)    NM_003916  1 
Calcium channel, voltage-dependent, beta 1 subunit (CACNB1)    NM_000723  1 
Potassium voltage-gated channel, KQT-like subfamily, member 4 (KCNQ4)   NM_004700  1 
Vitelliform macular dystrophy (Best disease, bestrophin) (VMD2)    NM_004183  151 
 
Other known (Miscellaneous) 
Membrane frizzled-related protein (MFRP)      NM_031433  5 
STIP1 homology and U-Box containing protein 1 (STUB1)     NM_005861  1 
Hypoxia-inducible factor 1, alpha subunit inhibitor (HIF1AN)     NM_017902  1 
Calumenin (CALU)         NM_001219  1 
CDC26 subunit of anaphase promoting complex (CDC26)     NM_139286  1 
Sterile alpha and HEAT/Armadillo motif protein, ortholog of Drosophila (SARM)   NM_015077  4 
Heterogeneous nuclear ribonucleoprotein D-like (HNRPDL)     NM_005463  1 
Lysyl oxidase-like 1 (LOXL1)        NM_005576  1 
Mitochondrial ribosomal protein S6 (MRPS6)      NM_032476  1 
Ubiquitin-like 5 (UBL5)        NM_024292  3 
Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa (POLR2E)    NM_002695  1 
MutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1)    NM_000249  1 
Nucleobindin 1 (NUCB1)        NM_006184  1 
Ubiquinol-cytochrome c reductase complex (7.2 kD) (HSPC051)    NM_013387  1 
Progesterone receptor membrane component 1 (PGRMC1)     NM_006667  3 
Phosphatidylinositol glycan, class S (PIGS)      NM_033198  3 
Ribosomal protein S3 (RPS3)        NM_001005  3 
Serine/arginine repetitive matrix 2 (SRRM2)      NM_016333  1 
Single-stranded DNA binding protein 2 (SSBP2)      NM_012446  1 
Protein kinase, lysine deficient 4 (PRKWNK4)      NM_032387  2 
Protective protein for beta-galactosidase (galactosialidosis) (PPGB)    NM_000308  1 
Serine (or cysteine) proteinase inhibitor, clade A, member 5 (SERPINA5)   NM_000624  3 
Staufen, RNA binding protein (Drosophila) (STAU)     NM_017453  1 
T-cell leukemia translocation altered gene (TCTA)     NM_022171  1 
 
Unknown  
t-complex-associated-testis-expressed 1-like 1 (TCTEL1)     NM_006519  1 
DNA segment, Chr 15, Wayne State University 75, (D15Wsu75e)    XM_039495  3 
Aldolase A, fructose-bisphosphate pseudogene 2 (ALDOAP2)    M21191   1 
Serine hydrolase-like (SERHL)       NM_170694  3 
Tripartite motif-containing 41 (TRIM41)       NM_033549  1 
Hypothetical protein (MGC32043)        NM_144582  1 
Hypothetical protein (GL009)         NM_032492  1 
Mannosidase, beta A, lysosomal-like (MANBAL)      NM_022077  1 
Succinate dehydrogenase complex, subunit C, 15kDa (SDHC)    NM_003001  1 
Chromosome 6 open reading frame 49 (C6orf49)      NM_017601  2 
Chromosome 20 open reading frame 16 (C20orf16)     NM_019025  3 
Hypothetical protein (MGC2477)       NM_024099  1 
Chloride intracellular channel 6 (CLIC6)       NM_053277  1 
Similar to RIKEN cDNA 2610030J16 gene (MGC2541)     NM_080670  1 
Hypothetical protein (MGC23937)         NM_145052  1 
Hypothetical protein (MGC14161)        NM_032892  1 
Chromosome 20 open reading frame 43 (C20orf43)     NM_016407  1 
WW domain binding protein 1 (WBP1)        NM_012477  2 
Component of oligomeric golgi complex 1 (COG1)     NM_018714  2 
Hypothetical protein (MGC10540)       NM_032353  3 
Serologically defined breast cancer antigen 84 (SDBCAG84)    NM_015966  4 
Seven transmembrane domain protein (NIFIE14)      NM_032635  1 
PTD009 protein (PTD009)        NM_016146  1 
Similar to DAZ associated protein 2; deleted in azoospermia associated  
Similar to cytochrome b (LOC284125)        XM_210340  1 
abhydrolase domain containing 6 (ABHD6)      NM_020676  11 
Similar to hypothetical protein PRO2831 (LOC283760)       XM_208826  3 
NICE-3 protein (NICE-3)         NM_015449  1 
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C/EBP-induced protein (LOC81558)       NM_030802  1 
Mannose-P-dolichol utilization defect 1 (MPDU1)      NM_004870  1 
similar to NADH1 (LOC349376)       XM_115915  2 
Hypothetical protein (DKFZp761G0122)       NM_152661  15 
Six transmembrane epithelial antigen of prostate 2 (STEAP2)    NM_152999  1 
Like mouse brain protein E46 (E46L)       NM_013236  2 
SPARC related modular calcium binding 2 (SMOC2)     NM_022138  1 
ADP-ribosylation factor-like 6 interacting protein (ARL6IP)     NM_015161  1 
S-adenosylhomocysteine hydrolase-like 1 (AHCYL1)     NM_006621  2 
Basic leucine zipper and W2 domains 2 (BZW2)      NM_014038  1 
Similar to RIKEN cDNA 1200015A19 (LOC127262)      XM_072073  1 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide  
N-acetylgalactosaminyltransferase 10 (GALNT10)      NM_017540  1 
Hypothetical protein (HSPC111)       NM_016391  1 
Hypothetical protein (MGC49942)       BC040148  1 
protein 2 (LOC150862)        XM_087029  2 
Hypothetical protein BC003515 (LOC154467)       XM_166346  3 
Similar to mitochondrial ribosomal protein L55 (LOC128308)     XM_059233  1 
Similar to hypothetical protein XP_101622 (LOC161145)     XM_101622  1 
LOC119587         XM_058409  11 
LOC149464         XM_097645  1 
LOC285148          XM_209490  1 
LOC286642          XM_212361  1 
LOC51256          NM_016495  2 
LOC283211          XM_210938  32 
LOC91549         XM_039115  1 
LOC151361         XM_098048  1 
Cystine-knot containing secreted protein (DKFZP564D206)     NM_015464  3 
DKFZp434N0419          XM_209007  1 
DKFZP547E1010         NM_015607  1 
DKFZP564K1964         NM_015544  35 
DKFZP564M082         NM_014042  1 
KIAA1094           NM_014908  1 
KIAA1608          NM_024820  1 
KIAA0759          NM_015305  1 
KIAA0556          AB011128  2 
KIAA0446          AB007915  1 
KIAA0445          NM_014675  1 
KIAA0157          NM_032182  1 
KIAA1189          XM_050508  8 
KIAA1576          NM_020927  9 
FLJ12076         NM_025187  1 
FLJ11305          NM_018386  1 
FLJ11756         NM_024606  4 
FLJ90119          NM_153347  7 
FLJ40773          NM_152666  5 
FLJ32069          NM_153033  1 
FLJ22055            NM_024779  2 
FLJ20580           NM_017887  2 
FLJ12089            NM_024552  6 
FLJ10803            NM_018224  1 
FLJ10504          NM_018116  1 
FLJ21032          NM_024906  6 
FLJ12287 similar to semaphorins       NM_022367  1 
Classification of 341 subtracted ESTs expressed in the human RPE into 18 functional 
groups. LocusLink accession numbers are shown along with the number of ESTs 
identified using BlastN program. This supports the view that the RPE is 
multifunctional. 
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